标签归档：合成

sussex-research中国代理

发表于由


sussex-research中国代理



Sussex Research Laboratories Inc.已经在碳水化合物领域工作了二十多年，并将我们的合成策略应用于看似无数的问题。我们已将复杂的碳水化合物系统应用于药物发现、药物递送、药物靶向、基于碳水化合物的疫苗开发、免疫疗法、治疗增强和诊断/生物分析分析开发。

 

定制合成

糖肽

我们制备多种定制糖肽，并在糖肽领域拥有多年经验。我们欢迎您的定制合成，并将调整我们的合成方法以满足您的特定需求。

寡糖

我们合成各种定制的二、三、四或更大的糖或糖胺聚糖 (GAG) 寡糖，并将利用我们的合成专业知识来满足我们合作伙伴的特定需求。

改性碳水化合物

我们制备各种特殊的改性碳水化合物和碳水化合物中间体。

其他糖系统

我们专注于多步定制合成，欢迎任何类型的碳水化合物合成项目。



药物靶向——GalNAc

使用与肝细胞中发现的 Ashwell-Morell 受体（去唾液酸糖蛋白受体或 ASGPR）结合的 N-乙酰半乳糖胺 (GalNAc) 偶联物靶向药物递送治疗有效载荷已成为一种递送方法，尤其是治疗性寡核苷酸。多年来，我们通过合成开发单聚体和多聚体碳水化合物配体（包括 GalNAc），在该领域活跃了很多年，用于包括药物靶向在内的应用。

疫苗开发——多糖化学

细菌是高度糖基化的病原体。糖结合疫苗已被证明是预防传染病的成功策略，预计 2021 年全球肺炎球菌疫苗市场将超过 80 亿美元。作为 CRO，我们一直是各种糖结合疫苗开发项目的重要贡献者包括多价（23 血清型）疫苗的临床前开发，该疫苗可能成为复杂的广谱肺炎球菌疫苗。

癌症——聚糖

与健康细胞相比，肿瘤细胞上的异常糖基化是癌症的标志，并且是所有癌症的共同特征。此外，细胞表面蛋白上的特定聚糖积极推动肿瘤的发展和进展。由于糖生物学的发现，药物发现和开发的新前沿正在实现。这些正在为以细胞表面聚糖为中心的新疗法铺平道路。从免疫检查点抑制剂的开发到治疗疫苗再到单克隆抗体，聚糖将以一种或另一种方式突出。近二十年来，我们一直是寡糖、糖氨基酸、糖肽和糖基化配体形式的癌症抗原的开发商。

碳水化合物-蛋白质（凝集素）相互作用

细胞表面装饰有密集且多样的碳水化合物结构（聚糖），这些结构与锚定在细胞膜中的蛋白质或脂质结合。这些可以统称为糖萼。在无数的功能中，特定的聚糖结构与互补的碳水化合物识别/结合蛋白凝集素结合，以调节细胞生理。有许多种类的凝集素，自由循环或与细胞表面连接，参与许多生物过程。研究较为活跃的两种是唾液酸结合免疫球蛋白型凝集素 (Siglecs) 和 β-半乳糖苷结合凝集素 (Galectins)。几种凝集素，包括去唾液酸糖蛋白受体 (ASGPR)，已被 FDA 批准用于靶向药物递送系统。扩大该领域的知识为治疗干预提供了新的机会。凭借 20 年合成多种聚糖系统的经验，我们在这里帮助推进该领域的发现和治疗应用。




关于“正牌代理商”栏目的声明

 

“正牌代理商”栏目设立的初衷是为了让读者在购买产品时能更快找到厂家的代理商，不用一张一张地翻名片，也不用担心买到水货和假货。基于这个初衷，我们收录了多个品牌的代理商，并在签订合同时进行了严格的审核。各厂家或代理商以合同的形式对其代理信息的真实性和准确性进行了保证。  然而，由于生物产品市场的复杂性，尽管我们进行了严格的审核，也不能保证信息的*准确和实时更新。基于此，今后我们会尽我们最大的努力去进行更严格的审核，也希望各厂家和代理商配合和谅解

       sussex-research常卖产品列表：                                                                                                        

货号 品名 规格 品牌
SI040110-50mg Diltiazem-d3.HCl 50mg sussex-research
SI040110-25mg Diltiazem-d3.HCl 25mg sussex-research
GA131015-250mg STn Antigen: Fmoc-Thr(Neu5Acα(2-6)GalNAc)-OH (Peracetate, Benzyl Ester) 250mg sussex-research
GA121015-250mg STn Antigen: Fmoc-Ser(Neu5Acα(2-6)GalNAc)-OH (Peracetate, Benzyl Ester) 250mg sussex-research
GA121000-500mg Tn Antigen: Fmoc-Ser(GalNAc(Ac)₃-α-D)-OH 500mg sussex-research
GA131000-500mg Tn Antigen: Fmoc-Thr(GalNAc(Ac)₃-α-D)-OH 500mg sussex-research
GA131000-25mg Tn Antigen: Fmoc-Thr(GalNAc(Ac)₃-α-D)-OH 25mg sussex-research
GA121000-25mg Tn Antigen: Fmoc-Ser(GalNAc(Ac)₃-α-D)-OH 25mg sussex-research
GA121015-25mg STn Antigen: Fmoc-Ser(Neu5Acα(2-6)GalNAc)-OH (Peracetate, Benzyl Ester) 25mg sussex-research
GA131015-25mg STn Antigen: Fmoc-Thr(Neu5Acα(2-6)GalNAc)-OH (Peracetate, Benzyl Ester) 25mg sussex-research
BL000010 Biotin DADPS Picolyl Azide Labeling Probe ea sussex-research
PE134010-25MG N-Acetylgalactosamine 25mg sussex-research
BT000070-0.5MG STn Antigen (Threonine, Biotin) 0.5mg sussex-research

 

sussex-research代理   sussex-research中国代理   sussex-research  sussex-research BT000070

无细胞蛋白质合成试剂盒 Transdirect insect cell

发表于由

无细胞蛋白质合成试剂盒
Transdirect insect cell

  • 产品特性
  • 相关资料
  • Q&A
  • 参考文献

来自昆虫培养细胞的无细胞蛋白质合成试剂盒无细胞蛋白质合成试剂盒 Transdirect insect cell

Transdirect insect cell

 


　　Sf21 昆虫培养细胞在杆状病毒表达系中有不错的成绩，Transdirect insect cell 以其提取液为底物，再活用从动物冲而来的合成合成系，这个系统带有由兔子网状红血球而来的合成系统，克服了合成量少的缺点，是无细胞蛋白质合成试剂盒。

 

 

◆特点


●　以杆状病毒表达系的 Sf21 细胞为底物

●　编码杆状病毒多角体蛋白基因 5UTR 的高效载体

●　是迄今为止唯一的从动物系的兔子网状红血球而来的试剂盒，蛋白质合成量更高，是普通试剂盒的20倍

无细胞蛋白质合成试剂盒 Transdirect insect cell

◆试剂盒内容


●　Insect cell Extract（黄色）×5支

●　Reaction Buffer（蓝色）×1支

●　4 mM Methionine（红色）×1支

●　0.5 μg/μL Control DNA（白色）×1支

●　0.5 μg/μL Ptd1 Vector（绿色）×1支

●　使用说明书

产品列表
产品编号 产品名称 产品规格 产品等级 备注
634-07601 Transdirect insect cell
无细胞蛋白质合成试剂盒		 40次 – –

Chiralix 代理

发表于由

Chiralix——手性分子专业供应商

Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供的研发服务，如复杂有机分子的合成等。

 

公司主要产品：

1、氨基酸类：包括各种以氨基酸为骨架的手性衍生物。

                                          

L-allysine ethylene acetal           L/D-homopropargylglycine

 

                    

L/D–bishomopropargylglycine   (2S,5R)-5-hydroxypipecolic acid hydrochloride

                      

(S/R)-4-oxopipecolic acid ethylene acetal  (S)-5-oxopipecolic acid ethylene acetal

(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid

                      

(S)-β3-phenylalanine          (S/R)-α-methyl-phenylglycine

 

D-tert-leucine

2、N-BOC保护的氨基酸骨架类

                                

Boc-L-allysine ethylene acetal          Boc-L-homopropargylglycine

                         

Boc-L/D-bishomopropargylglycine CHA salt

                          

(S)-Boc-β3-phenylalanine               (S)-Boc-α-methyl-phenylglycine

Boc-D-tert-leucine

 

3、N-CBZ 保护的氨基酸骨架类

 

                           

Cbz-L-allysine ethylene acetal         Cbz-L-homopropargylglycine

                        

Cbz-D-homopropargylglycine        Cbz-L-bishomopropargylglycine CHA salt

                      

Cbz-D-bishomopropargylglycine CHA salt       (S)-Cbz-β3-phenylalanine

                           

(S)-Cbz-α-methyl-phenylglycine CHA salt         Cbz-D-tert-leucine CHA salt

 

4、N-FMOC 保护的氨基酸骨架类

                

Fmoc-L-allysine ethylene acetal  Fmoc-L-homopropargylglycine

                        

Fmoc-D-homopropargylglycine   Fmoc-L-bishomopropargylglycine

 

                                

Fmoc-D-bishomopropargylglycine   Fmoc-cyclohexylglycine

            

Fmoc-D-cyclohexylglycine            Fmoc-L-β-azidoalanine

                   

Fmoc-L-γ-azidohomoalanine     Fmoc-L-δ-azidoornithine

           

Fmoc-L-ε-azidolysine           (S)-Fmoc-β3-phenylalanine

 

           (S/R)-Fmoc-α-methyl-phenylglycine    

Fmoc-D-tert-leucine

5、AZIDO氨基酸骨架类

                                   

4-azidobutanoic acid           5-azidopentanoic acid

                  

6-azidohexanoic acid           7-azidoheptanoic acid

                        

2-(azidomethyl)benzoic acid    3-(azidomethyl)benzoic acid

                  

4-(azidomethyl)benzoic acid     L-azidoalanine CHA salt

                     

D-azidoalanine CHA salt      L-azidoallylglycine CHA salt

                      

D-azidoallylglycine CHA salt       NG-Pmc-L-azidoarginine

                     

L-azidoasparagine DCHA salt   D-azidoasparagine DCHA salt

           

L/D-azidoaspartic acid mono-tert-butyl ester CHA salt

       

 

S-Trityl-L-azidocysteine CHA salt

L-azidoglutamic acid mono-tert-butyl ester CHA salt

D-azidoglutamic acid mono-tert-butyl ester CHA salt

 

  L-azidoglutamine DCHA salt

         

D-azidoglutamine DCHA salt    N-im-Trityl-L-azidohistidine CHA salt

     

L/D-azidoisoleucine CHA salt

          

L/D-azidoleucine CHA salt

   

L/D-azido-tert-leucine CHA salt    

        

L/D-azidomethionine CHA salt 

           

L/D-azidophenylalanine CHA salt

         

(S/R)-azido-α-methyl-phenylglycine

            

L/D-azidoserine CHA salt  

                

L/D-azidoserine tert-butyl ether CHA salt

                    

L-azidothreonine CHA salt        D-azidothreonine CHA salt

 

          

L/D-azidothreonine tert-butyl ether CHA salt

          

L/D-azidotryptophan CHA salt

       

L/D-azidotyrosine CHA salt

 

       

L/D-azidotyrosine tert-butyl ether CHA salt

 

        

L-azidovaline CHA salt

        

 

Fmoc-L-β-azidoalanine   Fmoc-L-γ-azidohomoalanine

          

Fmoc-L-δ-azidoornithine    Fmoc-L-ε-azidolysine

6、β2氨基酸骨架类

       

(S/R)-β2-homoalanine HCl salt

     

(S/R)-β2-homoleucine HCl salt

     

(S/R)-β2-homophenylalanine HCl salt

      

 

(S/R)-β2-homovaline HCl salt

7、FMOC保护的β2氨基酸骨架类

  

(S/R)-Fmoc-β2-homoalanine

       

(S/R)-Fmoc-β2-homoleucine

  

 

(S/R)-Fmoc-β2-homophenylalanine

 

  

(S/R)-Fmoc-β2-homovaline

8、CHROMOGENIC 及FLUOROGENIC氨基酸

                           

H-Arg(Boc)2-pNA                 H-Orn(Boc)-pNA

 

          

Fmoc-Orn-pNA · HCl              H-Arg(Boc)2-AMC

                 

H-Orn(Boc)-AMC                 Fmoc-Orn-AMC · HCl

                   

H-Lys(Boc)-AMC                       Fmoc-Lys-AMC · HCl

          

Bis(H-Arg(Boc)2)-rhodamine 110   Bis(H-Orn(Boc))-rhodamine 110

 

9、氨基乙醇及其衍生产品

2-deoxystreptamine dihydrobromide

bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine

                         

bis(N-Boc)-2-deoxystreptamine   bis(N-Cbz)-2-deoxystreptamine

                                 

6,8a-diepi-castanospermine    (S)-allylglycinol hydrochloride

                                  

 (R)-allylglycinol hydrochloride  (S)-propargylglycinol hydrochloride

 

 

                                

(R)-propargylglycinol hydrochloride  (S)-homopropargylglycinol hydrochloride

 

                             

(R)-homopropargylglycinol hydrochloride       (S)-bishomopropargylglycinol hydrochloride

                            

(R)-bishomopropargylglycinol hydrochloride (2S,5R)-5-hydroxypipecolic acid hydrochloride

(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid

10、CEREULIDE & 13C6-CEREULIDE（致吐毒素及其衍生品）

cereulide (50 µg/mL in acetonitrile)

Cereulide

13C6-cereulide (20 µg/mL in acetonitrile)

13C6-cereulide

11、STRIGOLACTONES & ANALOGUES（独脚金内酯及其类似物）

                           

(rac)-GR24                          (±)-strigol

 

                

(±)-5-deoxystrigol              (±)-2'-epi-5-deoxystrigol

 

                          

(±)-sorgolactone                           TIS108

                            

4-Br debranone                       4-CN debranone

 

Nijmegen-1

 

12、其它产品

         

Abamine oxalic acid salt     RR6

2,2,2-trichloroethoxysulfonyl chloride

2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate

(S)-β3-phenylalanine methyl ester hydrochloride

(3R,4R)-3,4-dihydroxycyclohexa-1,5-dienecarboxylic acid

6-methylcyclohex-1-enecarboxylic acid

 

热烈庆祝成为（POCH）Epoch Life Science公司中国代理

发表于由

公司概况：

基因合成服务及免费密码子优化

早在2004年我们完成了*基因合成，在这个生命科学时代（zui初时代Biolabs）我们已经发展成为一个专业基因合成公司。同行业的期刊以及上引用了我们大量的参考文献。下文，会告诉你更多有关我们的能力。在这个时代认真对待每一个项目就是注重速度与成本， 我们的博士专家们将利用她们在蛋白质生物化学、结构生物学、细胞生物学和分子生物学等方面广泛的专业知识帮你设计项目。把您的金钱风险降到zui小化，zui重要的是可以节约您的时间，从而努力帮您实现您的zui终目标。 我们的奉献不是总在一个方面，在这个生命科学时代里可以同时容纳数百项目与数以百计的训练有素的伙伴。高GC,串联重复等不会阻止我们。我们可以加速你任何梦想到的基因合成方面的研究。

部分产品信息及价格：

Cat.#Product NameSizePrice 

货号品名规格价格（人民币）

1460050GenCatch （TM） Blood &Tissue Genomic Mini-Prep Kit50 Mini Preps2227

1460250GenCatch （TM） Blood &Tissue Genomic Mini-Prep Kit250 Mini Preps7123

1470020GenCatch （TM） Blood Genomic DNA Midi and Maxi-Prep Kit25 Midi Preps2533

1470100GenCatch （TM） Blood Genomic DNA Midi and Maxi-Prep Kit50 Midi Preps8500

1480010GenCatch （TM） Blood Genomic DNA Midi and Maxi-Prep Kit10 Maxi Preps2533

1480050GenCatch （TM） Blood Genomic DNA Midi and Maxi-Prep Kit25 Maxi Preps8500

1560050GenCatch （TM） Plant Genomic DNA Purification System50 Mini Preps2686

1560250GenCatch （TM） Plant Genomic DNA Purification System250 Mini Preps9265

1580020GenCatch （TM） Plant Genomic DNA Purification System20 Maxi Preps3451

1660050GenCatch （TM） Total RNA Extraction System50 Mini Preps3451

1660250GenCatch （TM） Total RNA Extraction System250 Mini Preps12784

1670010GenCatch （TM） Total RNA Extraction System10 Midi Preps2150.5

1670050GenCatch （TM） Total RNA Extraction System50 Midi Preps6511

1680006GenCatch （TM） Total RNA Extraction System6 Maxi Preps2533

1680024GenCatch （TM） Total RNA Extraction System24 Maxi Preps6664

1760050GenCatch （TM） Plant RNA Purification System50 Mini Preps4063

1760250GenCatch （TM） Plant RNA Purification System250 Mini Preps14926

1780010GenCatch （TM） Plant RNA Purification System10 Maxi Preps2992

1860050GenCatch （TM） Viral RNA Mini-Prep Kit50 Mini Preps2992

1860250GenCatch （TM） Viral RNA Mini-Prep Kit250 Mini Preps10336

1910-050 SampleEconoSpinTM All-in-1 Mini Spin Columns for DNA/RNA extraction501445

1910-250EconoSpinTM All-in-1 Mini Spin Columns for DNA/RNA extraction2502465

1920-050 SampleEconoSpinTM All-in-1 Mini Spin Columns for DNA/RNA extraction501445

1920-250EconoSpinTM All-in-1 Mini Spin Columns for DNA/RNA extraction2502465

1940-250EconoSpinTM All-in-1 Mini Spin Columns for DNA/RNA extraction2502890

1970050GenCatch （TM） DNA Midi Columns50 Midi Column4590

1980010GenCatch （TM） DNA Maxi Columns10 Maxi Column2465

1980025GenCatch （TM） DNA Maxi Columns25 Maxi Column4760

1980050GenCatch （TM） DNA Maxi Columns50 Maxi Column8330

1980500GenCatch （TM） DNA Maxi Columns500 Maxi Column68850

2020-001EconoSpinTM All-in-1 Mini Spin Columns for DNA/RNA extraction11071

2030-050EconoSpinTM All-in-1 Mini Spin Columns for DNA/RNA extraction502550

2040-050EconoSpinTM All-in-1 Mini Spin Columns for DNA/RNA extraction503400

2160050GenCatch （TM） Plasmid DNA Mini-Prep Kit50 Mini Preps1496

2160250GenCatch （TM） Plasmid DNA Mini-Prep Kit250 Mini Preps3570

2170025GenCatch （TM） Plasmid DNA Midi and Maxi Kit25 Midi Preps3485

2170050GenCatch （TM） Plasmid DNA Midi and Maxi Kit50 Midi Preps5865

2180010GenCatch （TM） Plasmid DNA Midi and Maxi Kit10 Maxi Preps3145

2180025GenCatch （TM） Plasmid DNA Midi and Maxi Kit25 Maxi Preps6375

2260050GenCatch （TM） Gel Extraction Kit50 Mini Preps1496

2260250GenCatch （TM） Gel Extraction Kit250 Mini Preps3570

2360050GenCatch （TM） PCR Cleanup Kit50 Preps1496

2360250GenCatch （TM） PCR Cleanup Kit250 Preps3570

31-00110GenCarrier-1（TM）1ml （250 Tfx）3910

31-00120GenCarrier-2（TM）1ml （250 Tfx）3910

31-00130RNACarrier（TM）1ml （250 Tfx）4590

B401-150MX1 Buffer, 150 ml Resuspension Buffer （RNase A not included）1501105

B401-500MX1 Buffer, 500 ml Resuspension Buffer （RNase A not included）5001530

B402-150MX2 Buffer,150 ml Lysis Buffer, For User in Plasmid DNA Preparation1501105

B402-500MX2 Buffer, 500 ml Lysis Buffer, For User in Plasmid DNA Preparation5001530

B403-200MX3 Buffer, 200 ml Neutralization Buffer, For User in Plasmid DNA Preparation2001190

B403-500MX3 Buffer, 500 ml Neutralization Buffer, For User in Plasmid DNA Preparation5001615

B404-100WS Buffer, 100 ml Wash Buffer （5x Concentrate for 500 ml Buffer）, For User in Plasmid Preparation1001105

B404-400WS Buffer, 400 ml Wash Buffer （5x Concentrate for 2000 ml Buffer）, For User in Plasmid Preparation4001700

B405-200EB Buffer, 200 ml Elution Buffer, For User in Plasmid Preparation2001360

B405-50EB Buffer, 50 ml Elution Buffer, For User in Plasmid Preparation501020

B406-200GEX Buffer, 200 ml Gel Solubilization and Binding Buffer2001445

B406-500GEX Buffer, 500 ml Gel Solubilization and Binding Buffer5002125

B407-200PEX Buffer, 200 ml PCR Binding Buffer2001445

B407-500PEX Buffer, 500 ml PCR Binding Buffer5002125

B408-0.2gRNase A （20ug/ul）, RNase A Powder 0.2g, DNase Free0.2g2125

B408-1000RNase A （20ug/ul）, 1ml RNase A Solution （20mg/ml） for Plasmid Preparation1ml1394

B408-1gRNase A （20ug/ul）, RNase A Powder 1g, DNase Free1g5270

B408-400RNase A （20ug/ul）, 400 ul RNase A Solution （20mg/ml） for Plasmid Preparation4001105

P501-10PCReady Reagent10ml1445

P501-100PCReady Reagent100ml5134

P501-250PCReady Reagent250ml10846

P501-50PCReady Reagent50ml3366

 

 

引用我们基因合成服务的相关参考文献:

Adameyko, I., F. Lallemend, A. Furlan, N. Zinin, S. Aranda, S.S. Kitambi, A. Blanchart, R. Favaro, S. Nicolis, and M. Lübke. “Sox2 and Mitf Cross-Regulatory Interactions Consolidate Progenitor and Melanocyte Lineages in the Cranial Neural Crest.” Development 139, no. 2 （2012）: 397-410.

 

Alder, A., I. Holdermann, P. Beyer, and S. Al-Babili. “Carotenoid Oxygenases Involved in Plant Branching Catalyse a Highly Specific Conserved Apocarotenoid Cleavage Reaction.” Biochem. J 416, （2008）: 289-296.

 

Alvarez, J.P., I. Pekker, A. Goldshmidt, E. Blum, Z. Amsellem, and Y. Eshed. “Endogenous and Synthetic Micrornas Stimulate Simultaneous, Efficient, and Localized Regulation of Multiple Targets in Diverse Species.” The Plant Cell Online 18, no. 5 （2006）: 1134-1151.

 

Amanda, J., J.M. Hyser, V.V. Keasler, Y. Cang, and B.L. Slagle. “Hepatitis B Virus Regulatory Hbx Protein Binding to Ddb1 Is Required but Is Not Sufficient for Maximal Hbv Replication.” Virology, （2012）.

 

Antonczak, A.K., Z. Simova, and E.M. Tippmann. “A Critical Examination of Escherichia Coli Esterase Activity.” Journal of Biological Chemistry 284, no. 42 （2009）: 28795-28800.

 

Antonczak, A.K., Z. Simova, I.T. Yonemoto, M. Bochtler, A. Piasecka, H. Czapińska, A. Brancale, and E.M. Tippmann. “Importance of Single Molecular Determinants in the Fidelity of Expanded Genetic Codes.” Proceedings of the National Academy of Sciences 108, no. 4 （2011）: 1320-1325.

 

Araújo, J.A. “Produção De Quimosina B De Bos Taurus Em Pichia Pastoris.” （2008）.

 

Atsumi, S., A.F. Cann, M.R. Connor, C.R. Shen, K.M. Smith, M.P. Brynildsen, K.J.Y. Chou, T. Hanai, and J.C. Liao. “Metabolic Engineering of Escherichia Coli for 1-Butanol Production.” Metabolic engineering 10, no. 6 （2008）: 305-311.

 

Avedillo Diez, I., D. Zychlinski, E.G. Coci, M. Galla, U. Modlich, R.A. Dewey, A. Schwarzer, T. Maetzig, N. Mpofu, and E. Jaeckel. “Development of Novel Efficient Sin Vectors with Improved Safety Features for Wiskott-Aldrich Syndrome Stem Cell Based Gene Therapy.” Molecular pharmaceutics, （2011）.

 

Azizi, A., A. Arora, A. Markiv, D.J. Lampe, T. Miller, and A.S. Kang. “Ribosome Display of Combinatorial Antibody Libraries Derived from Mice Immunised with Heat-Killed Xylella Fastidiosa and the Selection of Mopb-Specific Single-Chain Antibodies.” Applied and environmental microbiology, （2012）.

 

Babi?, F., V. Venturi, and G. Maravi?-Vlahovi?ek. “Tobramycin at Subinhibitory Concentration Inhibits the Rhli/R Quorum Sensing System in a Pseudomonas Aeruginosa Environmental Isolate.” BMC infectious diseases 10, no. 1 （2010）: 148.

 

Bi, H., Q.H. Christensen, Y. Feng, H. Wang, and J.E. Cronan. “The Burkholderia Cenocepacia Bdsf Quorum Sensing Fatty Acid Is Synthesized by a Bifunctional Crotonase Homologue Having Both Dehydratase and Thioesterase Activities.” Molecular Microbiology, （2012）.

 

Biedler, J., and Z. Tu. “Evolutionary Analysis of the Kinesin Light Chain Genes in the Yellow Fever Mosquito Aedes Aegypti: Gene Duplication as a Source for Novel Early Zygotic Genes.” BMC evolutionary biology 10, no. 1 （2010）: 206.

 

Biersmith, B., Z. Liu, K. Bauman, and E.R. Geisbrecht. “The Dock Protein Sponge Binds to Elmo and Functions in Drosophila Embryonic Cns Development.” PLoS One 6, no. 1 （2011）: e16120.

 

Bloomer, W.A.C., H.M.A. VanDongen, and A.M.J. VanDongen. “Arc/Arg3. 1 Translation Is Controlled by Convergent N-Methyl-D-Aspartate and Gs-Coupled Receptor Signaling Pathways.” Journal of Biological Chemistry 283, no. 1 （2008）: 582-592.

 

Boddey, J.A., A.N. Hodder, S. Günther, P.R. Gilson, H. Patsiouras, E.A. Kapp, J.A. Pearce, T.F. de Koning-Ward, R.J. Simpson, and B.S. Crabb. “An Aspartyl Protease Directs Malaria Effector Proteins to the Host Cell.” Nature 463, no. 7281 （2010）: 627-631.

 

Bradley, H.J., L.E. Browne, W. Yang, and L.H. Jiang. “Pharmacological Properties of the Rhesus Macaque Monkey P2x7 Receptor.” British Journal of Pharmacology, （2011）.

 

BRANDÃO, NAA, MO CASTRO, and IAH PFRIMER. “Produção De Proteína Recombinante Do Hcv Para Fins Diagnósticos.”

 

Burré, J., H. Zimmermann, and W. Volknandt. “Identification and Characterization of Sv31, a Novel Synaptic Vesicle Membrane Protein and Potential Transporter.” Journal of neurochemistry 103, no. 1 （2007）: 276-287.

 

Bussey, K.A., E.A. Desmet, J.L. Mattiacio, A. Hamilton, B. Bradel-Tretheway, H.E. Bussey, B. Kim, S. Dewhurst, and T. Takimoto. “Pa Residues in the 2009 H1n1 Pandemic Influenza Virus Enhance Avian Influenza Virus Polymerase Activity in Mammalian Cells.” Journal of virology 85, no. 14 （2011）: 7020-7028.

 

Cho, H., H.R. McManus, S.L. Dove, and T.G. Bernhardt. “Supporting Information For: The Nucleoid Occlusion Factor Slma Is a DNA-Activated Ftsz Polymerization Antagonist.”

 

Couture, M., L.P. Vezina, and N. Landry. “Influenza Virus Immunizing Epitope.” Google Patents, 2009.

 

Craig, J.W., M.A. Cherry, and S.F. Brady. “Long-Chain N-Acyl Amino Acid Synthases Are Linked to the Putative Pep-Cterm/Exosortase Protein-Sorting System in Gram-Negative Bacteria.” Journal of bacteriology 193, no. 20 （2011）: 5707-5715.

 

Craveiro, K.I.C., J.E.G. Júnior, M.C.M. Silva, L.L.P. Macedo, W.A. Lucena, M.S. Silva, J.D.A.S. Júnior, G.R. Oliveira, M.T. Magalhaes, and A.D. Santiago. “Variant Cry1ia Toxins Generated by DNA Shuffling Are Active against Sugarcane Giant Borer.” Journal of biotechnology 145, no. 3 （2010）: 215-221.

 

CUNHA, C.E.P., P.L. MO, and F.R. CONCEIÇÃO. “Clonagem E Expressão Do Antígeno De Excreção E Secreção Tes-30 De Toxocara Canis Em Escherichia Coli.”

 

D’aoust, M., M. Couture, F. Ors, S. Trepanier, P. Lavoie, M. Dargis, L. Vezina, and N. Landry. “Influenza Virus-Like Particles （Vlps） Comprising Hemagglutinin.” US Patent 20,110,293,650, 2011.

 

D’Aoust, M.A., P.O. Lavoie, M.M.J. Couture, S. Trépanier, J.M. Guay, M. Dargis, S. Mongrand, N. Landry, B.J. Ward, and L.P. Vézina. “Influenza Virus‐Like Particles Produced by Transient Expression in Nicotiana Benthamiana Induce a Protective Immune Response against a Lethal Viral Challenge in Mice.” Plant biotechnology journal 6, no. 9 （2008）: 930-940.

 

Davis, R.W., J.A. Timlin, J.N. Kaiser, M.B. Sinclair, HD Jones, and T.W. Lane. “Accurate Detection of Low Levels of Fluorescence Emission in Autofluorescent Background: Francisella-Infected Macrophage Cells.” Microscopy and Microanalysis 16, no. 4 （2010）: 478-487.

 

De Breyne, S., Y. Yu, T.V. Pestova, and C.U.T. Hellen. “Factor Requirements for Translation Initiation on the Simian Picornavirus Internal Ribosomal Entry Site.” Rna 14, no. 2 （2008）: 367-380.

 

DE ESTROGÊNIO, P.D.O.S.R.H., and E.P. EM. “Produção Dos Receptores Humanos De Estrogênio E Progesterona Em Escherichia Coli Santos Junior, Alceu Gonçalves1; Aleixo, José Antonio Guimarães2; Conceição, Fabrício Rochedo3.”

 

de Oliveira Castro, M. “Expressão E Purificação De Uma Proteína Multiepítopo Recombinante Desenhada a Partir De Proteínas Do Vírus Da Hepatite C.” （2007）.

 

Diao, F., and B.H. White. “A Novel Approach for Directing Transgene Expression in Drosophila: T2a-Gal4 in-Frame Fusion.” Genetics, （2011）.

 

Dinh, T., and T.G. Bernhardt. “Using Superfolder Green Fluorescent Protein for Periplasmic Protein Localization Studies.” Journal of bacteriology 193, no. 18 （2011）: 4984-4987.

 

Evans, R.M., E.M. Behiry, L.H. Tey, J. Guo, E.J. Loveridge, and R.K. Allemann. “Catalysis by Dihydrofolate Reductase from the Psychropiezophile Morila Profunda.” ChemBioChem 11, no. 14 （2010）.

 

Franz, AWE, N. Jasinskiene, I. Sanchez‐Vargas, AT Isaacs, MR Smith, CCH Khoo, MS Heersink, AA James, and KE Olson. “Comparison of Transgene Expression in Aedes Aegypti Generated by Mariner Mos1 Transposition and Φc31 Site‐Directed Recombination.” Insect Molecular Biology, （2011）.

 

Galazka, J., B. Striepen, and B. Ullman. “Adenosine Kinase from< I> Cryptosporidium Parvum.” Molecular and biochemical parasitology 149, no. 2 （2006）: 223-230.

 

Guillaumond, F., A. Gréchez-Cassiau, M. Subramaniam, S. Brangolo, B. Peteri-Brünback, B. Staels, C. Fiévet, T.C. Spelsberg, F. Delaunay, and M. Teboul. “Krüppel-Like Factor Klf10 Is a Link between the Circadian Clock and Metabolism in Liver.” Molecular and cellular biology 30, no. 12 （2010）: 3059-3070.

 

Gurda, B.L., K.N. Parent, H. Bladek, R.S. Sinkovits, M.A. DiMattia, C. Rence, A. Castro, R. McKenna, N. Olson, and K. Brown. “Human Bocavirus Capsid Structure: Insights into the Structural Repertoire of the Parvoviridae.” Journal of virology 84, no. 12 （2010）: 5880-5889.

 

Han, X., and E.S. Boyden. “Multiple-Color Optical Activation, Silencing, and Desynchronization of Neural Activity, with Single-Spike Temporal Resolution.” PLoS One 2, no. 3 （2007）: e299.

 

Hanai, T., S. Atsumi, and JC Liao. “Engineered Synthetic Pathway for Isopropanol Production in Escherichia Coli.” Applied and environmental microbiology 73, no. 24 （2007）: 7814-7818.

 

Harris, B., I. Pereira, and E. Parkin. “Targeting Adam10 to Lipid Rafts in Neuroblastoma Sh-Sy5y Cells Impairs Amyloidogenic Processing of the Amyloid Precursor Protein.” Brain research 1296, （2009）: 203-215.

 

Hijazi, K., Y. Wang, C. Scala, S. Jeffs, C. Longstaff, D. Stieh, B. Haggarty, G. Vanham, D. Schols, and J. Balzarini. “Dc-Sign Increases the Affinity of Hiv-1 Envelope Glycoprotein Interaction with Cd4.” PLoS One 6, no. 12 （2011）: e28307.

 

Hires, S.A. Design, Development, and Use of Genetically-Encoded Fluorescent Reporters of Neural Activity: ProQuest, 2007.

 

Hornstein, E., A. Chen, S. Haramati, and E. Chapnik. “Methods of Diagnosing and Treating Motor Neuron Diseases.” Google Patents, 2009.

 

Huang, H.H., D. Camsund, P. Lindblad, and T. Heidorn. “Design and Characterization of Molecular Tools for a Synthetic Biology Approach Towards Developing Cyanobacterial Biotechnology.” Nucleic acids research 38, no. 8 （2010）: 2577-2593.

 

Husain, N., S. Obrani?, L. Koscinski, J. Seetharaman, F. Babi?, J.M. Bujnicki, G. Maravi?-Vlahovi?ek, and J. Sivaraman. “Structural Basis for the Methylation of A1408 in 16s Rrna by a Panaminoglycoside Resistance Methyltransferase Npma from a Clinical Isolate and Analysis of the Npma Interactions with the 30s Ribosomal Subunit.” Nucleic acids research 39, no. 5 （2011）: 1903-1918.

 

Ilkow, C.S., S. Goping, and T.C. Hobman. “The Rubella Virus Capsid Is an Anti-Apoptotic Protein That Attenuates the Pore-Forming Ability of Bax.” PLoS pathogens 7, no. 2 （2011）: e1001291.

 

Ingaramo, M., and D. Beckett. “Selectivity in Post-Translational Biotin Addition to Five Human Carboxylases.” Journal of Biological Chemistry 287, no. 3 （2012）: 1813-1822.

 

Isaacs, A.T., F. Li, N. Jasinskiene, X. Chen, X. Nirmala, O. Marinotti, J.M. Vinetz, and A.A. James. “Engineered Resistance to Plasmodium Falciparum Development in Transgenic Anopheles Stephensi.” PLoS pathogens 7, no. 4 （2011）: e1002017.

 

Jack, B.H.A., and M. Crossley. “Gata Proteins Work Together with Friend of Gata （Fog） and C-Terminal Binding Protein （Ctbp） Co-Regulators to Control Adipogenesis.” Journal of Biological Chemistry 285, no. 42 （2010）: 32405-32414.

 

Jackson, G., and C. Quan. “Methods for Molecular Detection.” Google Patents, 2009.

 

“Methods for Molecular Detection.” US Patent 20,110,306,054, 2011.

 

“Methods for Molecular Detection.” US Patent 20,120,015,359, 2012.

 

Jallu, V., M. Dusseaux, S. Panzer, M.F. Torchet, N. Hezard, J. Goudemand, A.G. de Brevern, and C. Kaplan. “Αiibβ3 Integrin: New Allelic Variants in Glanzmann Thrombasthenia, Effects on Itga2b and Itgb3 Mrna Splicing, Expression, and Structure–Function.” Human mutation 31, no. 3 （2010）: 237-246.

 

Janovjak, H., S. Szobota, C. Wyart, D. Trauner, and E.Y. Isacoff. “A Light-Gated, Potassium-Selective Glutamate Receptor for the Optical Inhibition of Neuronal Firing.” Nature neuroscience 13, no. 8 （2010）: 1027-1032.

 

Keasling, J.D., Y. Kang, E.J. Steen, and G. Bokinsky. “Product of Fatty Acid Esters from Biomass Polymers.” US Patent 20,120,115,195, 2012.

 

Kirby, K.A., B. Marchand, Y.T. Ong, T.P. Ndongwe, A. Hachiya, E. Michailidis, M.D. Leslie, D.V. Sietsema, T.L. Fetterly, and C.A. Dorst. “Structural and Inhibition Studies of the Rnase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse Transcriptase.” Antimicrobial Agents and Chemotherapy, （2012）.

 

Kralicek, A.V., M. Radjainia, N.A.B. Mohamad Ali, C. Carraher, R.D. Newcomb, and A.K. Mitra. “A Pcr-Directed Cell-Free Approach to Optimize Protein Expression Using Diverse Fusion Tags.” Protein expression and purification, （2011）.

 

Kreiner, M., Z. Li, J. Beattie, SM Kelly, HJ Mardon, and C.F. Van Der Walle. “Self-Assembling Multimeric Integrin Α5β1 Ligands for Cell Attachment and Spreading.” Protein Engineering Design and Selection 21, no. 9 （2008）: 553-560.

 

Lai, Y.J., F.M. Lin, M.J. Chuang, H.J. Shen, and T.F. Wang. “Genetic Requirements and Meiotic Function of Phosphorylation of the Yeast Axial Element Protein Red1.” Science’s STKE 31, no. 5 （2011）: 912.

 

Lalo, U., J.A. Roberts, and R.J. Evans. “Identification of Human P2x1 Receptor-Interacting Proteins Reveals a Role of the Cytoskeleton in Receptor Regulation.” Journal of Biological Chemistry 286, no. 35 （2011）

 

Le Brun, A.P., D.S.H. Shah, D. Athey, S.A. Holt, and J.H. Lakey. “Self-Assembly of Protein Monolayers Engineered for Improved Monoclonal Immunoglobulin G Binding.” International journal of molecular sciences 12, no. 8 （2011）: 5157-5167.

 

Lenormand, C., H. Bausinger, F. Gross, F. Signorino-Gelo, S. Koch, M. Peressin, D. Fricker, J.P. Cazenave, T. Bieber, and D. Hanau. “Hla-Dqa2 and Hla-Dqb2 Genes Are Specifically Expressed in Human Langerhans Cells and Encode a New Hla Class Ii Molecule.” The Journal of Immunology 188, no. 8 （2012）: 3903-3911.

 

Liao, J.C., S. Atsumi, M.P. Brynildsen, A.F. Cann, K.J. Chou, R.P.C. Shen, K.M. Smith, T. Hanai, and M.R. Connor. “Butanol Production by Recombinant Microorganisms.” Google Patents, 2008.

 

Liao, J.C., S. Atsumi, and T. Hanai. “Microorganism Engineered to Produce Isopropanol.” Google Patents, 2008.

 

Liew, P.X., C.L.C. Wang, and S.L. Wong. “Functional Characterization and Localization of a Bacillus Subtilis Sortase and Its Substrate and Use of This Sortase System to Covalently Anchor a Heterologous Protein to the B. Subtilis Cell Wall for Surface Display.” Journal of bacteriology 194, no. 1 （2012）: 161-175.

 

Lim, C.G. “Metabolic Engineering for High-Level Flavonoids and Stilbenes Production in Microorganisms.” STATE UNIVERSITY OF NEW YORK AT BUFFALO, 2012.

 

Lim, C.G., Z.L. Fowler, T. Hueller, S. Schaffer, and M.A.G. Koffas. “High-Yield Resveratrol Production in Engineered Escherichia Coli.” Applied and environmental microbiology 77, no. 10 （2011）: 3451-3460.

 

Lima, L.H.A. “Estudos Moleculares Dos Genes Xyl1 E Xyl2 De Candida Tropicalis Visando a Produção De Xilitol.” （2006）.

 

Liu, W., G. Wu, A.L. Tsai, and R.J. Kulmacz. “High-Yield Production, Purification and Characterization of Functional Human Duodenal Cytochrome B in an Escherichia Coli System.” Protein expression and purification, （2011）.

 

Ma, M., Z.L. Liu, and J. Moon. “Genetic Engineering of Inhibitor-Tolerant Saccharomyces Cerevisiae for Improved Xylose Utilization in Ethanol Production.” BioEnergy Research, （2012）: 1-11.

 

Madeira, L.M. “Expressão De Cyanovirin-N, Um Microbicida Anti-Hiv, Em Plantas.” （2008）.

 

Maitre, B., C. Angenieux, J. Salamero, D. Hanau, D. Fricker, F. Signorino, F. Proamer, J.P. Cazenave, B. Goud, and S. Tourne. “Control of the Intracellular Pathway of Cd1e.” Traffic 9, no. 4 （2008）: 431-445.

 

Markiv, A., B. Anani, R.V. Durvasula, and A.S. Kang. “Module Based Antibody Engineering: A Novel Synthetic Redantibody.” Journal of immunological methods 364, no. 1 （2011）: 40-49.

 

Markiv, A., R. Beatson, J. Burchell, R.V. Durvasula, and A.S. Kang. “Expression of Recombinant Multi-Coloured Fluorescent Antibodies in Gor-/Trxb-E. Coli Cytoplasm.” BMC biotechnology 11, no. 1 （2011）: 117.

Markiv, A., R.V. Durvasula, and A.S. Kang. “Fluorescent Fusion Polypeptides and Methods of Use.” Google Patents, 2011.

 

Matamá, T., R. Araújo, G.M. Gübitz, M. Casal, and A. Cavaco‐Paulo. “Functionalization of Cellulose Acetate Fibers with Engineered Cutinases.” Biotechnology progress 26, no. 3 （2010）: 636-643.

 

Michael, D.R., A.O. Phillips, A. Krupa, J. Martin, J.E. Redman, A. Altaher, R.D. Neville, J. Webber, M. Kim, and T. Bowen. “The Human Hyaluronan Synthase 2 （Has2） Gene and Its Natural Antisense Rna Exhibit Coordinated Expression in the Renal Proximal Tubular Epithelial Cell.” Journal of Biological Chemistry 286, no. 22 （2011）: 19523.

 

Moreira, S., F. Andrade, L. Domingues, and M. Gama. “Development of a Strategy to Functionalize a Dextrin-Based Hydrogel for Animal Cell Cultures Using a Starch-Binding Module Fused to Rgd Sequence.” BMC biotechnology 8, no. 1 （2008）: 78.

 

Morgan, R.A., S.A. Rosenberg, L. Zhang, and N.P. Restifo. “Inducible Interleukin-12.” US Patent 20,120,071,859, 2012.

 

Mortimer, S.E., D. Xu, D. McGrew, N. Hamaguchi, H.C. Lim, S.J. Bowne, S.P. Daiger, and L. Hedstrom. “Imp Dehydrogenase Type 1 Associates with Polyribosomes Translating Rhodopsin Mrna.” Journal of Biological Chemistry 283, no. 52 （2008）: 36354-36360.

 

Naesby, M., S.V.S. Nielsen, C.A.F. Nielsen, T. Green, T.Ø. Tange, E. Simón, P. Knechtle, A. Hansson, M.S. Schwab, and O. Titiz. “Yeast Artificial Chromosomes Employed for Random Assembly of Biosynthetic Pathways and Production of Diverse Compounds in Saccharomyces Cerevisiae.” Microbial cell factories 8, no. 1 （2009）: 45.

 

Ndongwe, T.P., A.O. Adedeji, E. Michailidis, Y.T. Ong, A. Hachiya, B. Marchand, E.M. Ryan, D.K. Rai, K.A. Kirby, and A.S. Whatley. “Biochemical, Inhibition and Inhibitor Resistance Studies of Xenotropic Murine Leukemia Virus-Related Virus Reverse Transcriptase.” Nucleic acids research 40, no. 1 （2012）: 345-359.

 

Neuteboom, L.W., K.O. Matsumoto, and D.A. Christopher. “An Extended Ae-Rich N-Terminal Trunk in Secreted Pineapple Cystatin Enhances Inhibition of Fruit Bromelain and Is Posttranslationally Removed During Ripening.” Plant physiology 151, no. 2 （2009）: 515-527.

 

Nunes, A.C.S. “Biofortificação De Plantas De Alface （Lactuca Sativa L.） Geneticamente Modificadas Para Aumento Do Teor De Folato.” （2010）.

 

Nunes, A.C.S., D.C. Kalkmann, and F.J.L. Aragao. “Folate Biofortification of Lettuce by Expression of a Codon Optimized Chicken Gtp Cyclohydrolase I Gene.” Transgenic research 18, no. 5 （2009）: 661-667.

 

O’Connor, T.P., J.M. Saucier, D. Daniluk, B.A. Stillman, R. Krah, Y. Rikihisa, Q. Xiong, M.J. Yabsley, D.S. Adams, and P.P.V.P. Diniz. “Evaluation of Peptide-and Recombinant Protein-Based Assays for Detection of Anti-Ehrlichia Ewingii Antibodies in Experimentally and Naturally Infected Dogs.” American journal of veterinary research 71, no. 10 （2010）: 1195-1200.

 

O’Sullivan, V.J., I. Barrette-Ng, E. Hommema, G.T. Hermanson, M. Schofield, S.C. Wu, C. Honetschlaeger, K.K.S. Ng, and S.L. Wong. “Development of a Tetrameric Streptavidin Mutein with Reversible Biotin Binding Capability: Engineering a Loop as an Exit Door for Biotin.” PLoS One 7, no. 4 （2012）: e35203.

 

Oka, T., E. Remue, K. Meerschaert, B. Vanloo, C. Boucherie, D. Gfeller, G. Bader, S. Sidhu, J. Vandekerckhove, and J. Gettemans. “Functional Complexes between Yap2 and Zo-2 Are Pdz Domain-Dependent, and Regulate Yap2 Nuclear Localization and Signalling1.” Biochem. J 432, （2010）: 461-472.

 

Parkin, E., and B. Harris. “A Disintegrin and Metalloproteinase （Adam）‐Mediated Ectodomain Shedding of Adam10.” Journal of neurochemistry 108, no. 6 （2009）: 1464-1479.

 

Parkin, E.T., C.A. Parr-Sturgess, and D.J. Rushton. “Ectodomain Shedding of the Notch Ligand Jagged1 Is Mediated by Adam17 but Is Not a Lipid Raft-Associated Event.” （2010）.

 

Parra, G., K. Bradnam, A.B. Rose, and I. Korf. “Comparative and Functional Analysis of Intron-Mediated Enhancement Signals Reveals Conserved Features among Plants.” Nucleic acids research 39, no. 13 （2011）: 5328-5337.

 

Péréfarres, F., M. Hoareau, F. Chiroleu, B. Reynaud, J. Dintinger, and J.M. Lett. “A Novel Synthetic Quantification Standard Including Virus and Internal Report Targets: Application for the Detection and Quantification of Emerging Begomoviruses on Tomato.” Virology Journal 8, no. 1 （2011）: 389.

 

PEREIRA, J.L., G.B. KLAFKE, G. MOREIRA, L.S. PINTO, F.R. CONCEIÇÃO, and F.P. LEITE. “Clonagem E Expressão Da Quimera Ltb/Gnrh Em Pichia Pastoris.”

 

Perez-Jimenez, R., A. Inglés-Prieto, Z.M. Zhao, I. Sanchez-Romero, J. Alegre-Cebollada, P. Kosuri, S. Garcia-Manyes, T.J. Kappock, M. Tanokura, and A. Holmgren. “Single-Molecule Paleoenzymology Probes the Chemistry of Resurrected Enzymes.” Nature structural & molecular biology 18, no. 5 （2011）: 592-596.

 

Pierre, M., J.A. Traverso, B. Boisson, S. Domenichini, D. Bouchez, C. Giglione, and T. Meinnel. “N-Myristoylation Regulates the Snrk1 Pathway in Arabidopsis.” The Plant Cell Online 19, no. 9 （2007）: 2804-2821.

 

Pisarev, A.V., A. Unbehaun, C.U.T. Hellen, and T.V. Pestova. “Assembly and Analysis of Eukaryotic Translation Initiation Complexes.” Methods in enzymology 430, （2007）: 147-177.

 

Porotto, M., Z. Salah, I. DeVito, A. Talekar, S.G. Palmer, R. Xu, I.A. Wilson, and A. Moscona. “The Second Receptor Binding Site of the Globular Head of the Newcastle Disease Virus Hemagglutinin-Neuraminidase Activates the Stalk of Multiple Paramyxovirus Receptor Binding Proteins to Trigger Fusion.” Journal of virology 86, no. 10 （2012）: 5730-5741.

 

Py-Daniel, K.R. “Atividades Amilolíticas Identificadas Em Bibliotecas Metagenômicas Da Microbiota Do Solo Do Cerrado.” （2011）.

 

Rochedo, F. “Clonagem E Expressão Dos Antígenos Recombinantes Tes-30 E Tes-120 De Toxocara Canis Em Pichia Pastoris Pepe, Michele Soares; Finger, Paula Fonseca; mo, Paula De Lima; Gonçales, Relber Aguiar; Leite, Fábio Pereira Leivas; Conceição.”

 

Sánchez-Rodríguez, S.P., L. Münch-Anguiano, O. Echeverría, G. Vázquez-Nin, M. Mora-Pale, J.S. Dordick, and I. Bustos-Jaimes. “< I> Human Parvovirus B19 Virus-Like Particles:< I> in Vitro Assembly and Stability.” Biochimie, （2011）.

 

Schanuel, S.M., K.A. Bell, S.C. Henderson, and A.R. McQuiston. “Heterologous Expression of the Invertebrate Fmrfamide–Gated Sodium Channel as a Mechanism to Selectively Activate Mammalian Neurons.” Neuroscience 155, no. 2 （2008）: 374-386.

 

Scherzinger, D., E. Scheffer, C. Bär, H. Ernst, and S. Al‐Babili. “The Mycobacterium Tuberculosis Orf Rv0654 Encodes a Carotenoid Oxygenase Mediating Central and Excentric Cleavage of Conventional and Aromatic Carotenoids.” FEBS Journal 277, no. 22 （2010）: 4662-4673.

 

Schindler, M., J. Schmökel, A. Specht, H. Li, J. Münch, M. Khalid, D.L. Sodora, B.H. Hahn, G. Silvestri, and F. Kirchhoff. “Inefficient Nef-Mediated Downmodulation of Cd3 and Mhc-I Correlates with Loss of Cd4+ T Cells in Natural Siv Infection.” PLoS pathogens 4, no. 7 （2008）: e1000107.

 

Shimada, T., Y. Takai, K. Shinohara, A. Yamasaki, K. Tominaga‐Yoshino, A. Ogura, A. Toi, K. Asano, N. Shintani, and A. Hayata‐Takano. “A Simplified Method to Generate Serotonergic Neurons from Mouse Embryonic Stem and Induced Pluripotent Stem Cells.” Journal of neurochemistry, （2012）.

 

Shtevi, A. “Design, Expression, and Testing of a Bivalent Subunit Botulism Vaccine for Use in Cattle.” James Cook University, 2009.

 

Sokolowska, M., H. Czapinska, and M. Bochtler. “Crystal Structure of the Ββα-Me Type Ii Restriction Endonuclease Hpy99i with Target DNA.” Nucleic acids research 37, no. 11 （2009）: 3799-3810.

 

“Hpy188i–DNA Pre-and Post-Cleavage Complexes—Snapshots of the Giy-Yig Nuclease Mediated Catalysis.” Nucleic acids research 39, no. 4 （2011）: 1554-1564.

 

Steen, E.J., R. Chan, N. Prasad, S. Myers, C.J. Petzold, A. Redding, M. Ouellet, and J.D. Keasling. “Metabolic Engineering of Saccharomyces Cerevisiae for the Production of N-Butanol.” Microb Cell Fact 7, no. 8 （2008）.

 

Steen, E.J., Y. Kang, G. Bokinsky, Z. Hu, A. Schirmer, A. McClure, S.B. Del Cardayre, and J.D. Keasling. “Microbial Production of Fatty-Acid-Derived Fuels and Chemicals from Plant Biomass.” Nature 463, no. 7280 （2010）: 559-562.

 

Sturms, R., S. Kakar, J. Trent III, and M.S. Hargrove. “Trema and Parasponia Hemoglobins Reveal Convergent Evolution of Oxygen Transport in Plants.” Biochemistry 49, no. 19 （2010）: 4085-4093.

 

Sydor, P.K. “Elucidation of the Prodiginine Biosynthetic Pathway in Streptomyces Coelicolor A3 （2）.” University of Warwick, 2010.

 

Timlin, J.A., R.M. Noek, J.N. Kaiser, M.B. Sinclair, H.D.T. Jones, R.W. Davis, and T.W. Lane. “Accurate Measurement of Cellular Autofluorescence Is Critical for Imaging of Host-Pathogen Interactions.” 6859, 68590A, 2008.

 

Todd, J.D., A.R.J. Curson, M. Kirkwood, M.J. Sullivan, R.T. Green, and A.W.B. Johnston. “Dddq, a Novel, Cupin‐Containing, Dimethylsulfoniopropionate Lyase in Marine Roseobacters and in Uncultured Marine Bacteria.” Environmental Microbiology 13, no. 2 （2011）: 427-438.

 

Tsai, A.L., V. Berka, E. Martin, and J.S. Olson. “A “Sliding-Scale Rule” for Selectivity between No, Co and O2 by Heme Protein Sensors.” Biochemistry, （2011）.

 

Uehara, T., T. Dinh, and T.G. Bernhardt. “Lytm-Domain Factors Are Required for Daughter Cell Separation and Rapid Ampicillin-Induced Lysis in Escherichia Coli.” Journal of bacteriology 191, no. 16 （2009）: 5094-5107.

 

Volz, J.C., R. Bártfai, M. Petter, C. Langer, G.A. Josling, T. Tsuboi, F. Schwach, J. Baum, J.C. Rayner, and H.G. Stunnenberg. “Pfset10, a< I> Plasmodium Falciparum Methyltransferase, Maintains the Active< I> Var Gene in a Poised State During Parasite Division.” Cell host & microbe 11, no. 1 （2012）: 7-18.

 

Wang, J., R.M. Pielak, M.A. McClintock, and J.J. Chou. “Solution Structure and Functional Analysis of the Influenza B Proton Channel.” Nature structural & molecular biology 16, no. 12 （2009）: 1267-1271.

 

Wang, Y., and Y.H.P. Zhang. “Overexpression and Simple Purification of the Thermotoga Maritima 6-Phosphogluconate Dehydrogenase in Escherichia Coli and Its Application for Nadph Regeneration.” Microbial cell factories 8, no. 1 （2009）: 30.

 

Wangh, L.J., J. Rice, N. Rice, and Y. Jia. “Reagents and Methods for Pcr.” US Patent 20,120,088,275, 2012.

 

Waugh, J.L., J. Celver, M. Sharma, R.L. Dufresne, D. Terzi, S.C. Risch, W.G. Fairbrother, R.L. Neve, J.P. Kane, and M.J. Malloy. “Association between Regulator of G Protein Signaling 9–2 and Body Weight.” PLoS One 6, no. 11 （2011）: e27984.

 

Yan, Y., C.C. Lee, and J.C. Liao. “Enantioselective Synthesis of Pure （R, R）-2, 3-Butanediol in Escherichia Coli with Stereospecific Secondary Alcohol Dehydrogenases.” Organic & biomolecular chemistry 7, no. 19 （2009）: 3914-3917.

 

Yang, S., M.E. Dudley, S.A. Rosenberg, and R.A. Morgan. “A Simplified Method for the Clinical-Scale Generation of Central Memory-Like Cd8+ T Cells after Transduction with Lentiviral Vectors Encoding Antitumor Antigen T-Cell Receptors.” Journal of Immunotherapy 33, no. 6 （2010）: 648.

 

Yang, S., N.K. Karne, S.L. Goff, M.A. Black, H. Xu, D. Bischof, K. Cornetta, S.A. Rosenberg, R.A. Morgan, and S.A. Feldman. “A Simple and Effective Method to Generate Lentiviral Vectors for Ex Vivo Gene Delivery to Mature Human Peripheral Blood Lymphocytes.” Human Gene Therapy, Part B: Methods, （2012）.

 

Yang, S., G. Luca, F. Liu, Y. Ji, Z. Yu, N.P. Restifo, S.A. Rosenberg, and R.A. Morgan. “In Vitro Generated Anti-Tumor T Lymphocytes Exhibit Distinct Subsets Mimicking in Vivo Antigen-Experienced Cells.” Cancer Immunology, Immunotherapy 60, no. 5 （2011）: 739-749.

 

Yu, J., D. Singh, N. Liu, J. Lian, T. Tan, and S. Chen. “Construction of a Glucose and Xylose Co-Fermenting Industrial Saccharomyces Cerevisiae by Expression of Codon-Optimized Fungal Xylose Isomerase.” Journal of Biobased Materials and Bioenergy 5, no. 3 （2011）: 357-364.

 

Zhang, L., S.P. Kerkar, Z. Yu, Z. Zheng, S. Yang, N.P. Restifo, S.A. Rosenberg, and R.A. Morgan. “Improving Adoptive T Cell Therapy by Targeting and Controlling Il-12 Expression to the Tumor Environment.” Molecular Therapy 19, no. 4 （2011）: 751-759.

 

Zhang, X., M. Li, A. Argawal, and K.Y. San. “Efficient Free Fatty Acid Production in< I> Escherichia Coli Using Plant Acyl-Acp Thioesterases.” Metabolic engineering, （2011）.

 

Zhao, Y. “The Role of the Nr4a Orphan Nuclear Receptor in Vascular Cells and Atherosclerosis.” （2011）.

 

Zimmermann, A.L., E.A. King, E. Dengler, S.R. Scogin, and W.H. Powell. “An Aryl Hydrocarbon Receptor Repressor from Xenopus Laevis: Function, Expression, and Role in Dioxin Responsiveness During Frog Development.” Toxicological sciences 104, no. 1 （2008）: 124-134.

 

Zschoernig, B., and U. Mahlknecht. “Carboxy-Terminal Phosphorylation of Sirt1 by Protein Kinase Ck2.” Biochemical and biophysical research communications 381, no. 3 （2009）: 372-377.

 

 

​chiralix CX72515说明书

发表于由

Chiralix是一家专业从事手性有机分子合成和供应的公司，Chiralix致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供优质的研发服务，如复杂有机分子的合成等。

chiralix CX72515说明书

4,5,5-trimethyldihydrofuran-2(3H)-one

Code: CX72515

CX72515-10MG
10 milligrams
CX72515-25MG
25 milligrams
CX72515-100MG
100 milligrams

规格

规格
CAS号 2981-96-6
化学名称 4,5,5-3甲基二氢呋喃-2(3H)-one
分子式 C 7 H 12 O 2
分子量 128.17
纯度 >98%

买chiralix，请认准chiralix代理商-上海金畔！

上海金畔chiralix书如下：

Synthose2018年报价表

发表于由

 

 

Synthose Inc位于加拿大多伦多北部的R&D 实验室和小型生产设备。专门为化学、生化、生物能源和治疗研究领域合成已建立的和新颖的化合物。我们是一个由碳水化合物合成专家组成的团队，由于创新的工艺开发和解决困难的碳水化合物和糖苷结合物项目的资源问题而迅速获得*的认可。通过现成的产品，定制的分子开发和研究伙伴关系，推动了R&D向前发展。

2018部分产品报价：

货号

品牌

规格

报价

品牌

AA634

3-Azido-3-deoxy-1,2-O-isopropylidene-α-D-allofuranose

500mg

1870

Synthose

AA700L

D-Allose-1,2,3,4,5,6-13C6

100mg

1700

Synthose

AD119

(R,S)-Ambrisentan acyl-β-D-glucuronide

1mg

2550

Synthose

AD201

Acemetacin acyl-β-D-glucuronide

1mg

2550

Synthose

AD332

6″-O-Acetyldaidzin

2mg

3400

Synthose

AD345

6″-O-Acetylgenistin

2mg

3400

Synthose

AD900

Aspirin acyl-β-D-glucuronide

1mg

2465

Synthose

AD908

Acetaminophen O-β-D-glucuronide

10mg

1615

Synthose

AD908

Acetaminophen O-β-D-glucuronide

10mg

1615

Synthose

AD916

Acetaminophen O-β-D-glucuronide, sodium salt

25mg

2125

Synthose

AD922

Acedoben acyl-β-D-glucuronide

5mg

1445

Synthose

AD928

N-D-Glucopyranosyl-5-aminosalicylic acid

1mg

3655

Synthose

AE100

1,4-Anhydroerythritol

10g

1700

Synthose

AE273

3-O-Acetyl-1,2:5,6-di-O-isopropylidene-α-D-erythro-Hex-3-enofuranose

250mg

2295

Synthose

AF134

2-Acetamido-1,3,4-tri-O-acetyl-2-deoxy-α-L-fucopyranose

5mg

2380

Synthose

AF166

2-Azidoethyl 3,4-O-isopropylidene-α-L-fucopyranoside

50mg

2295

Synthose

AF228

2-Azido-2-deoxy-L-fucopyranose

5mg

2295

Synthose

AF246

2-O-Acetyl-3,4-di-O-benzyl-L-fucopyranose

50mg

2720

Synthose

AF319

2-​Acetamido-2-​deoxy-​L-fucose

2mg

2380

Synthose

AF415

6-Azido-L-fucose

10mg

3740

Synthose

AF432

6-Azido-6-deoxy-D-galactose

250mg

2635

Synthose

AF491

4-​Aminophenyl β-​L-fucopyranoside

100mg

1870

Synthose

AF685

2-Aminoethyl 2-O-sulfo-α-L-fucopyranoside, sodium salt

10mg

2040

Synthose

AF712

2-Azido-2-deoxy-1-O-(thexyldimethylsilyl)-β-L-fucopyranose

100mg

3570

Synthose

AF820

2-Azidoethyl 2,3,4-tri-O-acetyl-α-L-fucopyranoside

100mg

4250

Synthose

AF924

2-Aminoethyl α-L-fucopyranoside

25mg

3060

Synthose

AF953

N-(ε-Aminocaproyl)-β-L-fucopyranosylamine

5mg

2550

Synthose

AG149

1,6-Anhydro-3-O-β-D-glucopyranosyl-β-D-glucopyranose

5mg

3060

Synthose

AG241

3-O-Acetyl-4-O-methyl-D-glucuronic acid

5mg

3230

Synthose

AG282

1,6-Anhydro-3-O-α-D-glucopyranosyl-β-D-glucopyranose

1mg

2295

Synthose

AG315

N-Acetyl-D-quinovosamine

10mg

3145

Synthose

AG327

1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-β-D-glucopyranose hydrochloride

10g

3910

Synthose

AG358

2-Azidoethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranoside

250mg

3995

Synthose

AG362

2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-D-glucopyranose

10g

2550

Synthose

AG364

2-Acetamido-1,3-di-O-acetyl-2-deoxy-4,6-O-isopropylidene-D-glucopyranose

1g

1700

Synthose

AG368

2-Acetamido-2-deoxy-4,6-O-isopropylidene-D-glucopyranose

2g

2550

Synthose

AG373

2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-β-D-glucopyranose

5g

2125

Synthose

AG413

6-Azido-6-deoxy-D-glucopyranose

50mg

1615

Synthose

AG414

4-Aminophenyl 1-thio-β-D-glucopyranoside

5mg

2210

Synthose

AG426

2-Acetamido-1,3,4-tri-O-acetyl-2,6-dideoxy-6-fluoro-D-glucopyranose

25mg

3740

Synthose

AG442

3-O-Allyl-β-D-glucopyranose

5g

3400

Synthose

AG450

3-O-Allyl-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose

10g

2890

Synthose

AG473

N-Azidoacetylglucosamine tetraacetate

25mg

2635

Synthose

AG477

Amiprilose hydrochloride

100mg

3145

Synthose

AG485

N-Azidoacetylglucosamine

5mg

3060

Synthose

AG517

1,6-Anhydro-2-O-β-D-glucopyranosyl-β-D-glucopyranose

5mg

3655

Synthose

AG546

Allyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside

1g

1190

Synthose

AG553

2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-N-(2-(2-(fluorenylmethyloxycarbonylamino)ethoxy)ethoxy)acetyl-aminohexanoyl-β-D-glucopyranosylamine

1mg

2550

Synthose

AG582

1,6-Anhydro-2-azido-3-O-benzyl-2-deoxy-β-D-glucopyranose

250mg

2805

Synthose

AG595

1,6-Anhydro-3-O-benzoyl-2-deoxy-2-fluoro-β-D-glucopyranose

50mg

2805

Synthose

AG621

6-O-Acetyl-D-glucopyranose

100mg

2805

Synthose

AG638

1,6-Anhydro-2-O-α-D-glucopyranosyl-β-D-glucopyranose

1mg

2465

Synthose

AG659

2-Acetamido-3,4,6-tri-O-acetyl-N-[N-(benzyloxycarbonyl)-ε-aminocaproyl]-2-deoxy-β-D-glucopyranosylamine

25mg

2550

Synthose

AG682

2-Acetamido-2-deoxy-N-(2-(2-aminoethoxy)ethoxy)acetylaminohexanoyl-β-D-glucopyranosylamine

1mg

5100

Synthose

AG707

1,6-Anhydro-2-azido-4-O-benzyl-2-deoxy-β-D-glucopyranose

500mg

6970

Synthose

AG708

1,6-Anhydro-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranose

1g

2550

Synthose

AG715

1,6-Anhydro-2-azido-2-deoxy-β-D-glucopyranose

1g

2550

Synthose

AG742

3-O-Acetyl-1,6-anhydro-2-azido-2',3'-di-O-benzyl-4',6'-O-benzylidene-2-deoxy-β-D-cellobiose

100mg

2720

Synthose

AG780

6-O-Acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose

500mg

5610

Synthose

AG793

1,6-Anhydro-2-deoxy-2-fluoro-β-D-glucopyranose

250mg

4505

Synthose

AG794

1,6-Anhydro-2-deoxy-2-iodo-β-D-glucopyranose

500mg

4250

Synthose

AG803

1,6-Anhydro-β-D-glucopyranose

5g

1700

Synthose

AG805

1,6-Anhydro-β-D-cellobiose

10mg

1360

Synthose

AG807

1,6-Anhydro-β-D-cellotriose

5mg

2125

Synthose

AG809

1,6-Anhydro-β-D-cellotetraose

2mg

2380

Synthose

AG811

1,6-Anhydro-β-D-cellopentaose

1mg

2125

Synthose

AG823

3-Acetylumbelliferyl β-D-glucopyranoside

10mg

2125

Synthose

AG824

1,6-Anhydro-β-D-glucofuranose

5mg

4080

Synthose

AG904

2-Azidoethyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside

1g

2890

Synthose

AG928

2-Acetamido-2-deoxy-β-D-glucopyranosyl azide

1g

2890

Synthose

AG931

2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl azide

2g

3060

Synthose

AG946

β-D-Glucopyranosyl azide

250mg

2040

Synthose

AG949

6-Amino-6-deoxy-D-glucopyranose, hydrochloride

25mg

2720

Synthose

AG952

6-Azido-6-deoxy-β-D-glucopyranosylamine

10mg

2295

Synthose

AG957

2-Aminophenyl 2,3,4-tri-O-acetyl-β-D-glucopyranosiduronate

100mg

2550

Synthose

AG962

2-Aminoethyl β-D-anthropyranoside

1mg

10370

Synthose

AI399

2-Acetyl-4-tetrahydroxybutyl imidazole

50mg

2550

Synthose

AI532

1-Ami-deoxy-scyllo-inositol

5mg

4505

Synthose

AI548

1-Ami-deoxy-scyllo-inositol hydrochloride

5mg

3825

Synthose

AI556

1-Ami,2-dideoxy-scyllo-inositol

2mg

3910

Synthose

AI729

2,5-Anhydro-L-iditol

5mg

2210

Synthose

AI800

1,6-Anhydro-3-O-benzyl-β-L-idopyranose

100mg

1785

Synthose

AI962

1,6-Anhydro-2,3,4-tri-O-benzyl-β-L-idopyranose

100mg

2550

Synthose

AL265

2,6-Anhydro-3-deoxy-D-glycero-D-galacto-non-2-enoic acid

1mg

1700

Synthose

AL356

2-Azidoethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-galactopyranoside

100mg

2210

Synthose

AL363

2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-β-D-galactopyranose

2g

2380

Synthose

AL367

2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-D-galactopyranosyl chloride

250mg

2975

Synthose

AL416

4-Aminophenyl 1-thio-β-D-galactopyranoside

25mg

2550

Synthose

AL485

4-Aminophenyl β-​D-lactopyranoside

100mg

3825

Synthose

AL683

β-D-Gal-PEG3-azide tetraacetate

250mg

3315

Synthose

AL684

β-D-Gal-PEG4-azide tetraacetate

50mg

2295

Synthose

AL770

1,6-Anhydro-3,4-O-isopropylidene-2-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-galactopyranose

5mg

2040

Synthose

AL812

1,6-Anhydro-3,4-O-isopropylidene-β-D-galactopyranose

1g

2550

Synthose

AL814

3-Acetamido-3,6-dideoxy-D-galactose

1mg

2550

Synthose

AL854

5-Acetamidofluorescein di-(β-D-galactopyranoside)

2mg

1870

Synthose

AL903

2-Azidoethyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside

500mg

2040

Synthose

AL915

2-Aminoethyl 3-O-(α-D-galactopyranosyl)-β-D-galactopyranoside

1mg

1615

Synthose

AL926

2-Azidoethyl β-D-galactopyranoside

500mg

4080

Synthose

AM709

2,5-Anhydro-1-O-trityl-D-mannitol

100mg

5780

Synthose

AM714

1,4-Anhydro-D-mannitol

100mg

2720

Synthose

AM725

1,5-Anhydro-D-mannitol

100mg

1615

Synthose

AM738

2,5-Anhydro-D-mannitol

100mg

2210

Synthose

AM853

4-Aminophenyl 3,6-di-O-(α-D-mannopyranosyl)-α-D-mannopyranoside

2mg

2720

Synthose

AM906

2-Azidoethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside

500mg

2465

Synthose

AM955

4-Aminophenyl α-D-mannopyranoside

100mg

2295

Synthose

AN416

N-Acetyl-9-​azido-​9-​deoxy-neuraminic acid

10mg

2550

Synthose

AN497

N-Acetylneuraminic acid methyl ester

1g

2125

Synthose

AR122

2-Acetamido-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)purine

250mg

3400

Synthose

AR243

2-Amino-2-deoxy-D-ribopyranose, hydrochloride

10mg

3060

Synthose

AR405

1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose

500mg

2635

Synthose

AR531

3-Amino-3-deoxy-D-ribose, hydrochloride

50mg

2465

Synthose

AR826

2-Amino-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)purine

1g

1700

Synthose

AR834

3-Azido-3-deoxy-4-hydroxymethyl-1,2-O-isopropylidene-α-D-ribofuranose

100mg

2550

Synthose

AR951

6-Azido-6-deoxy-2,3-O-isopropylidene-α-L-sorbofuranose

1g

2550

Synthose

AU611

3-O-Acetyl-1,2:5,6-di-O-isopropylidene-α-D-gulofuranose

500mg

2040

Synthose

AX804

1,5-Anhydro-β-D-xylofuranose

10mg

2125

Synthose

AZ400

(Z)-PUGNAc

5mg

1700

Synthose

AZ643

(E)-2-Acetamido-3,4,6-tri-O-benzoyl-2-deoxy-D-glucose 1-oxime

500mg

3740

Synthose

BA125

Benzyl 2-O-tosyl-β-D-arabinopyranoside

500mg

2890

Synthose

BA310

1,3-O-Benzylidene-D-arabinitol

5g

2890

Synthose

BA406

3-O-Benzyl-1,2:5,6-di-O-isopropylidene-α-D-allofuranose

10g

1955

Synthose

BA454

Benzyl β-D-arabinopyranoside

1g

1955

Synthose

BA923

Benzyl 3,4-O-isopropylidene-β-D-arabinopyranoside

500mg

2465

Synthose

BD108

Benzoic acid acyl-β-D-glucuronide

1mg

2380

Synthose

BD325

Biochanin A 7-O-β-D-glucuronide

5mg

2550

Synthose

BD540

Obeticholic acid acyl-β-D-glucuronide

1mg

1615

Synthose

BE205

Benzyl 2,3-O-isopropylidene-β-D-erythrofuranoside

1g

6375

Synthose

BG107

Benzyl 4,6-O-benzylidene-β-D-glucopyranoside

1g

2890

Synthose

BG162

Benzyl 2,3-di-O-benzyl-4-O-methyl-β-D-glucopyranosiduronic acid benzyl ester

50mg

3485

Synthose

BG179

N-(n-Butyl)-1-deoxynojirimycin hydrochloride

10mg

1870

Synthose

BG189

N-(n-Butyl)-1-deoxynojirimycin

10mg

2210

Synthose

BG213

Benzyl 2,3-di-O-benzyl-β-D-glucopyranoside

250mg

2720

Synthose

BG262

Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside

2g

2040

Synthose

BG337

Benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-β-D-glucopyranoside

250mg

5185

Synthose

BG369

Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-β-D-glucopyranoside

1g

3145

Synthose

BG371

Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-α-D-glucopyranoside

250mg

2635

Synthose

BG400

3-O-Benzyl-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose

5g

1700

Synthose

BG421

Benzyl 3-O-allyl-2-O-benzyl-β-D-glucopyranoside

500mg

3315

Synthose

BG446

Benzyl 3-O-allyl-4,6-O-benzylidene-β-D-glucopyranoside

500mg

3740

Synthose

BG446

Benzyl 3-O-allyl-4,6-O-benzylidene-β-D-glucopyranoside

1g

6035

Synthose

BG453

3-O-Benzyl-D-glucopyranose

1g

1785

Synthose

BG455

Benzyl 2,3,4-tri-O-benzyl-β-D-glucopyranoside

100mg

5100

Synthose

BG491

6-O-Benzoyl-3-O-benzyl-1,2-O-isopropylidene-5-O-mesyl-α-D-glucofuranose

1g

2380

Synthose

BG504

Benzyl β-D-glucopyranoside

1g

2720

Synthose

BG528

Benzyl 3-O-allyl-β-D-glucopyranoside

1g

2125

Synthose

BG590

2,3,6,2',3',4',6'-Hepta-O-acetyl-α-D-lactosyl bromide

1g

1530

Synthose

BG603

2,3,4-Tri-O-benzyl-D-glucopyranuronic acid benzyl ester

100mg

3995

Synthose

BG620

Benzyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside

250mg

2210

Synthose

BG661

Benzyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside

1g

2040

Synthose

CD440

5-​Chloro-​8-​hydroxyquinoline β-D-glucuronide

5mg

3570

Synthose

CD516

Curcumin 4-O-β-D-glucuronide

1mg

2720

Synthose

CD705

Celecoxib carboxylic acid acyl-β-D-glucuronide

1mg

3145

Synthose

CD866

Caffeic acid 3-O-β-D-glucuronide

2mg

2720

Synthose

CF579

2-Chloroethyl α-L-fucopyranoside

50mg

2550

Synthose

CF605

Cellobiulose

2mg

2312

Synthose

DA100

1,6:3,4-Dianhydro-β-D-altropyranose

25mg

2125

Synthose

DA218

3-Deoxy-D-arabino-hexonic acid, calcium salt

10mg

2125

Synthose

DA257

3,5-Di-O-benzoyl-2-deoxy-2-fluoro-α-D-arabinofuranosyl bromide

500mg

1870

Synthose

DA300

2,3:4,5-Di-O-isopropylidene-D-arabinitol

1g

1615

Synthose

DA400

2,3:4,5-Di-O-isopropylidene-D-arabinose

500mg

2890

Synthose

DA538

3-Deoxy-5,6-O-isopropylidene-D-arabino-hexonic acid, γ-lactone

100mg

1785

Synthose

DA800

1,6:3,4-Dianhydro-2-O-benzyl-β-D-altropyranose

500mg

8160

Synthose

DA945

3-Deoxy-3-fluoro-D-allose

10mg

2380

Synthose

EG124

Ethyl 3-O-benzyl-2-O-levulinoyl-1-thio-β-D-glucopyranoside

500mg

3060

Synthose

EG178

Ethyl 3-O-benzyl-2-O-(4-methoxybenzyl)-1-thio-β-D-glucopyranosiduronic acid benzyl ester

100mg

3230

Synthose

EG195

Ethyl 3-O-allyl-4-O-benzyl-2-O-naphthylmethyl-1-thio-β-D-glucopyranoside

100mg

2720

Synthose

EG227

Ethyl 2-deoxy-1-thio-2-trichloroacetylamino-β-D-glucopyranoside

500mg

3655

Synthose

EG351

Ethyl 4-O-allyl-3,6-di-O-benzyl-2-O-levulinoyl-1-thio-β-D-glucopyranoside

100mg

3230

Synthose

EG390

Ethyl 3,4,6-tri-O-acetyl-2-deoxy-1-thio-2-trichloroacetylamino-β-D-glucopyranoside

500mg

2210

Synthose

EG448

Ethyl 3-O-allyl-4,6-O-benzylidene-1-thio-β-D-glucopyranoside

1g

2040

Synthose

EG501

Ethyl 3-O-allyl-4,6-O-benzylidene-2-O-naphthylmethyl-1-thio-β-D-glucopyranoside

100mg

2720

Synthose

EG579

Ethyl 2-O-benzoyl-3-O-benzyl-1-thio-β-D-glucopyranoside

1g

2380

Synthose

EG632

Ethyl 3,4-di-O-benzyl-2-O-levulinoyl-1-thio-β-D-glucopyranosiduronic acid benzyl ester

100mg

4335

Synthose

EG656

Ethyl 3-O-allyl-4-O-benzyl-2-O-naphthylmethyl-1-thio-β-D-glucopyranosiduronic acid benzyl ester

100mg

4080

Synthose

FD327

Formononetin 7-O-β-D-glucuronide, sodium salt

5mg

1360

Synthose

FD582

Gemfibrozil acyl-β-D-glucuronide

1mg

2465

Synthose

FD594

Fenofibric acid acyl-β-D-glucuronide

2mg

4930

Synthose

FD741

Febuxostat acyl-β-D-glucuronide

1mg

2295

Synthose

FF533

2-Fluoroethyl α-L-fucopyranoside

5mg

2040

Synthose

FG129

6-O-Feruloyl-D-glucose

10mg

2040

Synthose

FG265

Flurbiprofen D-glucitol ester

25mg

2805

Synthose

FG374

2-Formylphenyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside

1g

2210

Synthose

FL210

Floridoside

25mg

3485

Synthose

FL385

2-O-(α-L-Fucopyranosyl)-D-galactose

5mg

3400

Synthose

FL426

2-Fluoro-4-nitrophenyl 2-azido-2-deoxy-β-D-galactopyranoside

10mg

2210

Synthose

FL448

6-​Deoxy-​6-​fluoro-D-galactopyranose

100mg

2550

Synthose

FM277

Flurbiprofen D-mannitol ester

25mg

1785

Synthose

GA820

2-O-α-D-Glucopyranosyl-L-ascorbic acid

1g

1020

Synthose

GE452

β-D-Glucopyranosyl-(1-2)-D-erythrofuranose

1mg

1530

Synthose

GF630

4-O-α-D-Galactopyranosyl-D-sucrose

5mg

4760

Synthose

GF635

4-O-β-D-Galactopyranosyl-D-sucrose

5mg

4760

Synthose

GG100L

D-Glucose-1,6-13C2

100mg

2380

Synthose

GG110L

D-Glucose-1-13C

500mg

2125

Synthose

GG232

D-Globotriose

5mg

3230

Synthose

GG248

D-Globotriose undecaacetate

10mg

3230

Synthose

GG306L

D-Glucofuranuronic acid, γ-lactone-1,6-13C2

100mg

2380

Synthose

GG433

Gallic acid 3-O-β-D-glucopyranoside

5mg

2295

Synthose

HD322

Hesperetin 7-O-β-D-glucuronide

5mg

1360

Synthose

HD324

Hesperetin 3'-O-β-D-glucuronide

5mg

1360

Synthose

HD326

Hesperetin 7,3'-di-O-β-D-glucuronide

5mg

2040

Synthose

HG270

Hesperetin 7-O-β-D-glucopyranoside

1mg

1445

Synthose

HG804

β-D-Cellobiosan hexaacetate

1g

1700

Synthose

HG812

2,3,6,2',3',4',6'-Hepta-O-acetyl-1-O-trichloroacetimidoyl-D-cellobioside

500mg

3315

Synthose

HI549

1,2,3,4,5,6-Hexa-O-acetyl-myo-inositol

10g

2040

Synthose

HM802

2,3,6,2',3',4',6'-Hepta-O-acetyl-D-maltose

1g

1955

Synthose

HM818

2,3,2',3',4',6'-Hexa-O-acetyl-1,6-anhydro-β-D-maltose

250mg

2720

Synthose

HS124

2,3,4,6,3',4',6'-Hepta-O-benzoyl-D-sucrose

250mg

2635

Synthose

HX610

Hexadecyl β-D-xylopyranoside

100mg

2465

Synthose

ID106

Indomethacin acyl-β-D-glucuronide

1mg

3060

Synthose

ID209

Isosorbide-5-mononitrate

100mg

1615

Synthose

ID262

Isosorbide-2-mononitrate

25mg

3315

Synthose

ID301

Isosorbide-5-mononitrate 2-O-β-D-glucuronide

1mg

2040

Synthose

ID302L

Isosorbide-5-mononitrate-1,2,3,4,5,6-13C6

1mg

4930

Synthose

ID316

Isosorbide-2-mononitrate 5-O-β-D-glucuronide

2mg

2720

Synthose

ID328

6-Iodo-Diosmin

1mg

2635

Synthose

ID500

(R,S)-Ibuprofen acyl-β-D-glucuronide

1mg

1955

Synthose

IE200

2,3-O-Isopropylidene-D-erythrofuranose

500mg

2975

Synthose

KD102

(R,S)-Ketoprofen acyl-β-D-glucuronide

1mg

2890

Synthose

KD323

Kaempferol 3-O-β-D-glucuronide

1mg

2380

Synthose

KZ300

Kifunensine

1mg

1530

Synthose

LD700

Lumiracoxib acyl-β-D-glucuronide

1mg

3145

Synthose

LG134

Linamarin

25mg

1530

Synthose

LG204

Levoglucosenone

250mg

2550

Synthose

LL642

β-D-Lactopyranosyl azide heptaacetate

25mg

3060

Synthose

LL809

β-D-Lactopyranose octaacetate

2g

2295

Synthose

MA295

Methyl 2-deoxy-2-fluoro-L-arabinofuranoside

100mg

3230

Synthose

MA536

Methyl β-L-arabinopyranoside

1g

1615

Synthose

MA780

Methyl 3,4-O-isopropylidene-2-O-tosyl-β-D-arabinopyranoside

1g

2805

Synthose

MD105

Mefenamic acid acyl-β-D-glucuronide

1mg

3570

Synthose

MD319

Mitiglinide acyl-β-D-glucuronide

1mg

2295

Synthose

MD334

6″-O-Malonyldaidzin

2mg

3740

Synthose

MD347

6″-O-Malonylgenistin

1mg

2210

Synthose

MD492

Memantine N-β-D-glucuronide

5mg

3230

Synthose

MD610

Memantine lactose adduct

10mg

2125

Synthose

MD822

Mycophenolic acid O-β-D-glucuronide

1mg

1530

Synthose

MD823

Mycophenolic acid acyl-β-D-glucuronide

1mg

2380

Synthose

MD824

Mycophenolic acid O-β-D-glucopyranoside

1mg

1955

Synthose

MF125

N-Methyl-Topiramate

25mg

3060

Synthose

MF203

4-Methylphenyl 2,3,4-tri-O-acetyl-1-thio-β-L-fucopyranoside

500mg

3995

Synthose

MG104

4-Methoxyphenyl 2,3,6-tri-O-acetyl-β-D-glucopyranoside

250mg

4675

Synthose

MG105

4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside

5g

1700

Synthose

ND208

Norethindrone 17-O-β-D-glucuronide

1mg

2040

Synthose

ND329

Naringenin 7-O-β-D-glucuronide

1mg

1530

Synthose

ND353

Genistin

25mg

2805

Synthose

ND422

(R,S)-Norfluoxetine N-β-D-glucuronide

1mg

2550

Synthose

ND600

(R,S)-Naproxen acyl-β-D-glucuronide

1mg

1955

Synthose

ND775

Naloxone 3-O-β-D-glucuronide

1mg

3740

Synthose

ND800

Niacin acyl-β-D-glucuronide

1mg

2125

Synthose

NF407

4-Nitrophenyl β-L-fucopyranoside

250mg

2720

Synthose

NF438

4-Nitrophenyl 2,3,4-tri-O-acetyl-β-L-fucopyranoside

500mg

2805

Synthose

NG221

2-Naphthalenyl β-D-glucopyranosiduronic acid, sodium salt

25mg

3060

Synthose

NG419

4-Nitrophenyl 1-thio-β-D-glucopyranoside

100mg

2550

Synthose

NG427

2-Nitrophenyl α-D-glucopyranoside

100mg

3060

Synthose

NG808

N-(n-Nonyl)-1-deoxynojirimycin

5mg

1615

Synthose

NG817

2-Nitrophenyl β-D-glucuronide

100mg

2550

Synthose

NG819

2-Nitrophenyl 2,3,6,2',3',4',6'-hepta-O-acetyl-β-D-cellobioside

100mg

1360

Synthose

NG865

2-NBDG

5mg

2635

Synthose

NI530

neo-​Inositol

25mg

3995

Synthose

NL429

2-Nitrophenyl α-D-galactopyranoside

100mg

2210

Synthose

NL431

3-Nitrophenyl α-D-galactopyranoside

100mg

1955

Synthose

NL440

4-Nitrophenyl β-​D-lactopyranoside

500mg

3570

Synthose

NL447

4-Nitrophenyl β-​D-lactopyranoside heptaacetate

250mg

3910

Synthose

NL536

4-Nitrophenyl α-D-galactopyranoside

1g

1445

Synthose

NL542

4-Nitrophenyl α-D-galactopyranoside tetraacetate

1g

1700

Synthose

NM414

4-Nitrophenyl α-D-mannopyranoside

100mg

1700

Synthose

NM851

4-Nitrophenyl 3,6-di-O-(α-D-mannopyranosyl)-α-D-mannopyranoside

2mg

2040

Synthose

PD107

Valproic acid acyl-D-glucuronide

1mg

2295

Synthose

PF943

Phenyl 2-azido-2-deoxy-1-seleno-α-D-fucopyranoside

100mg

3485

Synthose

PG103

1,2,3,4,6-Penta-O-acetyl-1-thio-β-D-glucopyranose

1g

2975

Synthose

PG459

Propyl 2-acetamido-2-deoxy-β-D-glucopyranoside

100mg

2040

Synthose

PG478

Pentyl β-D-glucopyranoside

500mg

2890

Synthose

PG608

2,3,4,3',4'-Penta-O-isovaleryl-sucrose

250mg

3825

Synthose

PG922

Phenyl 4,6-O-benzylidene-β-D-glucopyranoside

2g

2210

Synthose

PI250

1,2,3,4,6-Penta-O-acetyl-L-idopyranose

100mg

2125

Synthose

PL107

1,2,3,4,6-Penta-O-benzoyl-α-D-galactopyranose

2g

2890

Synthose

PL121

1,2,3,4,6-Penta-O-acetyl-1-thio-β-D-galactopyranose

500mg

2635

Synthose

PL454

Propargyl α-D-galactopyranoside

100mg

2465

Synthose

PL533

Propyl β-D-lactopyranoside

50mg

3060

Synthose

PL718

1,2,3,5,6-Penta-O-tertbutyldimethylsilyl-α-D-galactofuranose

1g

3570

Synthose

PL732

Propargyl 2,3,4,6-O-tetra-O-acetyl-α-D-galactopyranoside

250mg

3655

Synthose

PL931

Phenyl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-1-seleno-α-D-galactopyranoside

250mg

2890

Synthose

RD206

Ramipril acyl β-D-glucuronide

1mg

3655

Synthose

RD300

Repaglinide acyl-β-D-glucuronide

1mg

2295

Synthose

RD408

Rhein acyl-β-D-glucuronide

1mg

3825

Synthose

RG863

Resorufin β-D-lactoside

10mg

2550

Synthose

RX175

Resorufin β-D-xylobioside

1mg

2210

Synthose

SD109

Salicylic acid acyl-β-D-glucuronide

1mg

2465

Synthose

SD501

Sulindac acyl-β-D-glucuronide

1mg

2635

Synthose

SD502

Sulindac sulfide acyl-β-D-glucuronide

1mg

3060

Synthose

SD503

Sulindac sulfone acyl-β-D-glucuronide

1mg

3060

Synthose

SZ100

Swainsonine

2mg

1870

Synthose

TA162

2,3,5-Tri-O-benzoyl-β-D-arabinofuranosyl fluoride

250mg

3060

Synthose

TA358

1,2,4,6-Tetra-O-acetyl-3-deoxy-3-fluoro-β-D-allopyranoside

25mg

2805

Synthose

TA358

1,2,4,6-Tetra-O-acetyl-3-deoxy-3-fluoro-β-D-allopyranoside

50mg

4590

Synthose

TA419

2,3,5-Tri-O-acetyl-D-arabinonic acid, γ-lactone

1g

2550

Synthose

TA580

2,3,4-Tri-O-acetyl-α-L-arabinopyranosyl bromide

1g

2380

Synthose

TA735

1,3,5-Tri-O-benzoyl-α-D-arabinofuranose

250mg

2805

Synthose

TD101

misartan acyl-β-D-glucuronide

1mg

1615

Synthose

TD204

Tarenflurbil acyl-β-D-glucuronide

1mg

2465

Synthose

TD307

Gestodene-17-O-β-D-glucuronide

1mg

2040

Synthose

TD468

3,5,6-Trichloro-2-pyridinol O-β-D-glucuronide

2mg

2550

Synthose

TD505

Tolmetin acyl-β-D-glucuronide

1mg

2040

Synthose

TD673

Tolcapone 3-O-β-D-glucuronide

1mg

2125

Synthose

TD972

Tapentadol O-β-D-glucuronide

1mg

2295

Synthose

TF211

1,2,3,4-Tetra-O-acetyl-α-L-fucopyranose

1g

1700

Synthose

TF329

3,4,6-Tri-O-acetyl-1,2-O-isopropylidene-β-D-fructofuranose

500mg

2465

Synthose

TF584

2,3,4-Tri-O-acetyl-α-L-fucopyranosyl bromide

250mg

2805

Synthose

TG254

2,3,4-Tri-O-isobutyryl-1-O-trichloroacetimidoyl-α-D-glucopyranuronic acid methyl ester

100mg

2210

Synthose

TG271

2,​3,​4,​6-​Tetra-​O-​methyl-D-glucopyranose

100mg

2720

Synthose

TG298

3,4,6-Tri-O-acetyl-2-azido-2-deoxy-β-D-glucopyranosyl trichloroacetimidate

100mg

1700

Synthose

TG313

1,2,3,4-Tetra-O-isobutyryl-β-D-glucopyranuronic acid methyl ester

1g

2890

Synthose

TG439

1,2,4,6-Tetra-O-acetyl-3-O-allyl-β-D-glucopyranose

1g

1615

Synthose

TG508

2,3,4,6-Tetra-O-benzyl-D-glucopyranose

10g

2295

Synthose

TX534

1,2,3,4-Tetra-O-acetyl-β-D-xylopyranose

5g

2380

Synthose

TX763

2,3,4-Tri-O-acetyl-D-xylopyranosyl trichloroacetimidate

250mg

3485

Synthose

TX958

2,3,4-Tri-O-acetyl-β-D-xylopyranosyl azide

1g

2720

Synthose

XG132

3-O-β-D-Xylopyranosyl-D-glucuronic acid

1mg

1530

Synthose

XX397

D-Xylobiose

50mg

2550

Synthose

XX944

α-D-Xylopyranosyl azide

25mg

2550

Synthose

XX956

β-D-Xylopyranosyl azide

250mg

2550

Synthose

ZD507

Zomepirac acyl-β-D-glucuronide

1mg

2380

Synthose

ZD728

Zidovudine O-β-D-glucuronide

5mg

1700

Synthose

 

我们公司优势是强大的采购，

1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，

2：货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，

3：提供加急服务，一般1-2周到货，超过时限加急费全免

4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是价格低廉,因为价格低廉意味着没有服务.

5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司

6：我们*的品牌是：Antibody Research Corporation，arcticzymes，Biorelevant，AmberGen, Inc. ，clemente-associates，clodronaiposomes，Columbia Biosciences，enzyme research，Gene Bridges GmbH，Genovis，AmberGen, Inc.  Biotechnology GmbH，Haematologic Technologies HTI Haemtech，hookelabs，Immudex，Innovative Research of America，inspiralis ，List Biological Laboratories, Inc.，lumafluor，Microsurfaces，multiplicom，nanotools，Pel-Freez Biologicals，pentapharm，progen，Protein Ark，QA-Bio,Inc，QA-Bio,IncQuickZyme Biosciences，Teknova，TriLink BioTechnologies, Inc.，Zyagen Laboratories 等

7：我们还是invitrogen,qiagen,Midland BioProducts Corporationam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发，欢迎合作。

 

 

 

 

Synthose中国代理,Synthose上海代理，Synthose北京代理，Synthose广东代理， Synthose江苏代理Synthose湖北代理，Synthose天津代理,Synthose黑龙江代理,Synthose内蒙古代理,Synthose吉林代理,Synthose福建代理,Synthose江苏代理, Synthose浙江代理, Synthose四川代理,

Synthose中国代理,Synthose上海代理，Synthose北京代理，Synthose广东代理， Synthose江苏代理Synthose湖北代理，Synthose天津代理,Synthose黑龙江代理,Synthose内蒙古代理,Synthose吉林代理,Synthose福建代理,Synthose江苏代理, Synthose浙江代理, Synthose四川代理,

Clearsynth常卖产品简介

发表于由

 

Clearsynth是一家以技术为基础的研究驱动型企业，拥有参考标准和研究化学品库存。我们的目标是通过合成复杂且难以制造的化合物，使研究界能够加速发现。

我们专注于创新有机化学和*复杂分子、稳定同位素标记化合物、代谢物、杂质、葡糖苷酸、手性化合物、共轭杂质和放射性标记化合物的合成。我们还承接复杂分子或“难以合成”的化合物/中间体的合成。

Clearsynth常卖产品简介

Sapropterin 13C 15N3 bistrifluoroacetate

 

 

CAS 17528-72-2(Unlabeled)

关于 Sapropterin 13C 15N3 双三氟y酸盐的详细信息

目录号 CS-O-03245
类别 稳定同位素
中国科学院 17528-72-2（未标记）
摩尔 473.27 克/摩尔
分子F

C₁₂¹³CH₁₇F₆N₂¹⁵N₃O₇

 
贮存 长期存放在冰箱（2-8°C）中

Pembrolizumab

CAS 1374853-91-4

目录号 CS-O-11198
类别 派姆单抗 API 标准
父 API 派姆单抗
中国科学院 1374853-91-4
摩尔 146286.29 克/摩尔
分子F C 2 9 2 H 4 4 2 N 7 8 O 8 6 S 3
贮存 2-8°C

Epinephrine D3

CAS 1217733-17-9

目录号 CS-O-02818
类别 肾上腺素稳定同位素
父 API 肾上腺素
中国科学院 1217733-17-9
摩尔 186.22 克/摩尔
分子F C 9 H 1 0 D 3 NO 3
贮存 2-8°C

 

N-Desmethyl Pirenzepine

CAS 63257-31-8

目录号 CS-T-52258
类别 代谢物
中国科学院 63257-31-8
摩尔 337.38 克/摩尔
分子F C₁₈H₁₉N₅O₂
贮存 长期存放在冰箱（2-8°C）中

 

empbiotech NC-0101-E025.0-001说明书

发表于由

Emp BIOTECH成立于1993年，专注于有机合成，生物分子改性和纯化，为生命科学界提供的试剂和服务。

我们生产精细化学品，DNA合成试剂，分子生物学工具，色谱介质和相关产品。此外，我们还提供合同有机合成，蛋白质和核酸标签，肽合成，咨询和分析服务。

此外，我们对非放射性检测系统，合成有机和聚合物化学和净化服务领域持续关注。我们的新型检测平台结合了非酶化学发光信号放大和荧光增强策略，均由合成创新支持。

emp BIOTECH的产品和服务包括：
 

  • 荧光探针，接头，半抗原，修饰的核苷和核苷酸的合成
  • 蛋白质的标记和结合物的纯化
  • 定制合成的尺寸从亚微米量到200升批量反应
  • 化学发光敏化剂，前体和电子转移标记物的合成
  • 为生命科学分销和销售试剂，试剂盒和精细化学品
  • 制造和包装纯净，高品质的精细化学品
  • 特种溶剂，混合物和试剂的制造
  • 制造用于修饰和/或纯化DNA和蛋白质的产品
  • 制造凝胶过滤柱，旋转柱和多孔过滤板

寡核苷酸合成试剂

emp BIOTECH提供多种高纯度试剂，溶剂和标记分子，用于自动化寡核苷酸合成。

每种试剂均在严格的质量控制下生产，符合GMP / GLP协议。通过在惰性气氛下使用专业填充设备，水含量保持小化。使用Karl-Fischer电量滴定法，GC-MS，HPLC和一些在emp BIOTECH 专门开发的其他分析技术来维持纯度。

可用的包装形式：

每种溶剂都有以下标准配置：

 

  • 450毫升琥珀色玻璃瓶，标准美国螺纹28-400（即ABI，Mermade）
  • 2.5升琥珀色玻璃瓶，带DIN GL45螺纹
  • 4 L琥珀色玻璃瓶，带DIN GL45螺纹或美制螺纹38-430
  • 不锈钢（1.4571或1.4301）滚筒，带有G2“Tri-Sure Closure，尺寸从10L到200L不等。鼓的额定值为1.5 bar。

 

 

empbiotech NC-0101-E025.0-001说明书

Hyacinth BMT Crystals (5-Benzylmercaptotetrazole, BTT)

风信子BMT晶体（5-苄基巯基四唑，BTT）

货号：NC-0101-E025.0-001

CAS编号

21871-47-6

 经验公式：

C8H8N4S

分子量：

192,24克/摩尔

 

核酸合成的活化剂。

苄基巯基四唑（BMT，BTT）是用于DNA或RNA的化学合成的有效活化剂。已显示BMT在偶联时间，偶联效率，较低的亚磷酰胺消耗和较低的DNA和RNA的n-1杂质外观方面优于ETT，DCI和四唑。对于RNA，这允许常规合成长度超过40个碱基对的较长寡核苷酸。非爆炸性，BMT比1H-四唑明显更安全。此外，使用BMT的偶联效率很​​大程度上不依赖于RNA合成中使用的2'-O-保护的亚磷酰胺单体，并且可以与TBDMS，O-甲基，TOM®或ACE®一起使用。

 

 

chiralix公司介绍

发表于由

chiralix公司介绍

简要描述：Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。

详细介绍

产品咨询

 

      Chiralix——手性分子专业供应商

Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供优质的研发服务，如复杂有机分子的合成等。

 

公司主要产品：

1、氨基酸类：包括各种以氨基酸为骨架的手性衍生物。

 

货号 品名 化学名 CAS号 分子量 分子式 Synonyms 纯度 包装 价格
CX90418-1G L-allysine ethylene acetal (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid 215054-80-1 189.21 C8 H15 N O4 H-Aea-OH 99% 1 G 6200
CX90418-2G L-allysine ethylene acetal (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid 215054-80-1 189.21 C8 H15 N O4 H-Aea-OH 99% 2 G 10600
CX90418-5G L-allysine ethylene acetal (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid 215054-80-1 189.21 C8 H15 N O4 H-Aea-OH 99% 5 G 19900
CX60325-200MG D-homopropargylglycine (R)-2-aminohex-5-ynoic acid 211054-02-3 127.14 C6 H9 N O2 H-D-Hpg-OH >98% 200 MG 4800
CX60325-500MG D-homopropargylglycine (R)-2-aminohex-5-ynoic acid 211054-02-3 127.14 C6 H9 N O2 H-D-Hpg-OH >98% 500 MG 9800
CX60325-1G D-homopropargylglycine (R)-2-aminohex-5-ynoic acid 211054-02-3 127.14 C6 H9 N O2 H-D-Hpg-OH >98% 1 G 16000
CX80065-500MG Fmoc-L-homopropargylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid 942518-21-0 349.38 C21 H19 N O4 Fmoc-Hpg-OH >97% 500 MG 11200
CX80065-1G Fmoc-L-homopropargylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid 942518-21-0 349.38 C21 H19 N O4 Fmoc-Hpg-OH >97% 1 G 18400
CX90138-200MG L-homopropargylglycine (S)-2-aminohex-5-ynoic acid 98891-36-2 127.14 C6 H9 N O2 H-Hpg-OH >98% 200 MG 4800
CX90138-500MG L-homopropargylglycine (S)-2-aminohex-5-ynoic acid 98891-36-2 127.14 C6 H9 N O2 H-Hpg-OH >98% 500 MG 9800
CX90138-1G L-homopropargylglycine (S)-2-aminohex-5-ynoic acid 98891-36-2 127.14 C6 H9 N O2 H-Hpg-OH >98% 1 G 16000
CX56292-500MG (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid 108646-25-9 156.14 C7 H8 O4   >97% 500 MG 6000
CX56292-1G (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid 108646-25-9 156.14 C7 H8 O4   >97% 1 G 9800
CX24022-500MG (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid 38127-17-2 155.15 C7 H9 N O3   >98% 500 MG 6000
CX24022-1G (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid 38127-17-2 155.15 C7 H9 N O3   >98% 1 G 9800
CX41399-1G (S)-beta3-phenylalanine (S)-3-amino-3-phenylpropanoic acid 40856-44-8 165.19 C9 H11 N O2   99% 1 G 2200
CX41399-2G (S)-beta3-phenylalanine (S)-3-amino-3-phenylpropanoic acid 40856-44-8 165.19 C9 H11 N O2   99% 2 G 3800
CX41399-5G (S)-beta3-phenylalanine (S)-3-amino-3-phenylpropanoic acid 40856-44-8 165.19 C9 H11 N O2   99% 5 G 7200
CX64691-1G D-tert-leucine (R)-2-amino-3,3-dimethylbutyric acid 26782-71-8 131.17 C6 H13 N O2 H-D-tert-Leu-OH 99% 1 G 2200
CX64691-2G D-tert-leucine (R)-2-amino-3,3-dimethylbutyric acid 26782-71-8 131.17 C6 H13 N O2 H-D-tert-Leu-OH 99% 2 G 3800
CX64691-5G D-tert-leucine (R)-2-amino-3,3-dimethylbutyric acid 26782-71-8 131.17 C6 H13 N O2 H-D-tert-Leu-OH 99% 5 G 7200
CX97471-500MG (S)-alpha-methyl-phenylglycine (S)-2-amino-2-phenylpropanoic acid 13398-26-0 165.19 C9 H11 N O2 (S)-H-Mpg-OH >98% 500 MG 5200
CX97471-1G (S)-alpha-methyl-phenylglycine (S)-2-amino-2-phenylpropanoic acid 13398-26-0 165.19 C9 H11 N O2 (S)-H-Mpg-OH >98% 1 G 9000
CX97471-2G (S)-alpha-methyl-phenylglycine (S)-2-amino-2-phenylpropanoic acid 13398-26-0 165.19 C9 H11 N O2 (S)-H-Mpg-OH >98% 2 G 14800
CX58692-1G (S)-allylglycinol hydrochloride (S)-2-aminopent-4-en-1-ol hydrochloride 926660-03-9 137.61 C5 H12 Cl N O   >98% 1 G 7400
CX58692-2G (S)-allylglycinol hydrochloride (S)-2-aminopent-4-en-1-ol hydrochloride 926660-03-9 137.61 C5 H12 Cl N O   >98% 2 G 12800
CX40529-1G (S)-propargylglycinol hydrochloride (S)-2-aminopent-4-yn-1-ol hydrochloride Not available 135.59 C5 H10 Cl N O   >98% 1 G 8200
CX40529-2G (S)-propargylglycinol hydrochloride (S)-2-aminopent-4-yn-1-ol hydrochloride Not available 135.59 C5 H10 Cl N O   >98% 2 G 14000
CX80916-500MG bis(N-Cbz)-2-deoxystreptamine benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate 6216-32-6 430.45 C22 H26 N2 O7 bis-Z-2-DOS >95% 500 MG 6200
CX80916-1G bis(N-Cbz)-2-deoxystreptamine benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate 6216-32-6 430.45 C22 H26 N2 O7 bis-Z-2-DOS >95% 1 G 10800
CX93851-100MG (2S,5R)-5-hydroxypipecolic acid hydrochloride (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride 824943-40-0 181.62 C6 H12 Cl N O3   >98% 100 MG 3800
CX93851-500MG (2S,5R)-5-hydroxypipecolic acid hydrochloride (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride 824943-40-0 181.62 C6 H12 Cl N O3   >98% 500 MG 12600
CX93851-1G (2S,5R)-5-hydroxypipecolic acid hydrochloride (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride 824943-40-0 181.62 C6 H12 Cl N O3   >98% 1 G 19600
CX19922-1G (S)-beta3-phenylalanine methyl ester hydrochloride (S)-methyl 3-amino-3-phenylpropanoate hydrochloride 144494-72-4 215.68 C10 H14 Cl N O2   >98% 1 G 3000
CX19922-2G (S)-beta3-phenylalanine methyl ester hydrochloride (S)-methyl 3-amino-3-phenylpropanoate hydrochloride 144494-72-4 215.68 C10 H14 Cl N O2   >98% 2 G 5200
CX19922-5G (S)-beta3-phenylalanine methyl ester hydrochloride (S)-methyl 3-amino-3-phenylpropanoate hydrochloride 144494-72-4 215.68 C10 H14 Cl N O2   >98% 5 G 9800
CX62577-10MG 6,8a-diepi-castanospermine (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol 106798-21-0 189.21 C8 H15 N O4   >98% 10 MG 3600
CX62577-50MG 6,8a-diepi-castanospermine (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol 106798-21-0 189.21 C8 H15 N O4   >98% 50 MG 11800
CX25404-1G Fmoc-L-azidoornithine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid 1097192-04-5 380.40 C20 H20 N4 O4 Fmoc-Orn(N2)-OH >98% 1 G 3400
CX25404-5G Fmoc-L-azidoornithine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid 1097192-04-5 380.40 C20 H20 N4 O4 Fmoc-Orn(N2)-OH >98% 5 G 12000
CX23880-5MG rac-GR24 (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one 76974-79-3 298.29 C17 H14 O5   >98% 5 MG 5000
CX23880-20MG rac-GR24 (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one 76974-79-3 298.29 C17 H14 O5   >98% 20 MG 15000
CX23880-100MG rac-GR24 (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one 76974-79-3 298.29 C17 H14 O5   >98% 100 MG 35000
CX38605-1G Fmoc-L-allysine ethylene acetal (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid Not available 411.45 C23 H25 N O6 Fmoc-Aea-OH >97% 1 G 7200
CX38605-2G Fmoc-L-allysine ethylene acetal (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid Not available 411.45 C23 H25 N O6 Fmoc-Aea-OH >97% 2 G 12400
CX59650-1G Fmoc-L-azidohomoalanine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid 942518-20-9 366.37 C19 H18 N4 O4 Fmoc-Azh-OH >98% 1 G 3400
CX59650-5G Fmoc-L-azidohomoalanine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid 942518-20-9 366.37 C19 H18 N4 O4 Fmoc-Azh-OH >98% 5 G 12000
CX94894-200MG L-bishomopropargylglycine (S)-2-aminohept-6-ynoic acid 835627-45-7 141.17 C7 H11 N O2 H-Bpg-OH >98% 200 MG 4400
CX94894-500MG L-bishomopropargylglycine (S)-2-aminohept-6-ynoic acid 835627-45-7 141.17 C7 H11 N O2 H-Bpg-OH >98% 500 MG 9000
CX94894-1G L-bishomopropargylglycine (S)-2-aminohept-6-ynoic acid 835627-45-7 141.17 C7 H11 N O2 H-Bpg-OH >98% 1 G 14600
CX13745-1G (R)-propargylglycinol hydrochloride (R)-2-aminopent-4-yn-1-ol hydrochloride Not available 135.59 C5 H10 Cl N O   >98% 1 G 8200
CX13745-2G (R)-propargylglycinol hydrochloride (R)-2-aminopent-4-yn-1-ol hydrochloride Not available 135.59 C5 H10 Cl N O   >98% 2 G 14000
CX78500-1G (R)-allylglycinol hydrochloride (R)-2-aminopent-4-en-1-ol hydrochloride 926660-30-2 137.61 C5 H12 Cl N O   >98% 1 G 7400
CX78500-2G (R)-allylglycinol hydrochloride (R)-2-aminopent-4-en-1-ol hydrochloride 926660-30-2 137.61 C5 H12 Cl N O   >98% 2 G 12800
CX69324-500MG bis(N-Boc)-2-deoxystreptamine tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate 189157-45-7 362.42 C16 H30 N2 O7 bis-Boc-2-DOS >95% 500 MG 6200
CX69324-1G bis(N-Boc)-2-deoxystreptamine tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate 189157-45-7 362.42 C16 H30 N2 O7 bis-Boc-2-DOS >95% 1 G 10800
CX96388-1G Boc-L-allysine ethylene acetal (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid Not available 289.32 C13 H23 N O6 Boc-Aea-OH >98% 1 G 6200
CX96388-2G Boc-L-allysine ethylene acetal (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid Not available 289.32 C13 H23 N O6 Boc-Aea-OH >98% 2 G 10600
CX96388-5G Boc-L-allysine ethylene acetal (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid Not available 289.32 C13 H23 N O6 Boc-Aea-OH >98% 5 G 19900
CX42388-1G Cbz-L-allysine ethylene acetal (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid 852822-01-6 323.34 C16 H21 N O6 Z-Aea-OH >98% 1 G 6200
CX42388-2G Cbz-L-allysine ethylene acetal (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid 852822-01-6 323.34 C16 H21 N O6 Z-Aea-OH >98% 2 G 10600
CX42388-5G Cbz-L-allysine ethylene acetal (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid 852822-01-6 323.34 C16 H21 N O6 Z-Aea-OH >98% 5 G 19900
CX44656-500MG Boc-L-homopropargylglycine (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid 208522-16-1 227.26 C11 H17 N O4 Boc-Hpg-OH >98% 500 MG 9800
CX44656-1G Boc-L-homopropargylglycine (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid 208522-16-1 227.26 C11 H17 N O4 Boc-Hpg-OH >98% 1 G 16000
CX69013-500MG Cbz-L-homopropargylglycine (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid Not available 261.27 C14 H15 N O4 Z-Hpg-OH >98% 500 MG 9800
CX69013-1G Cbz-L-homopropargylglycine (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid Not available 261.27 C14 H15 N O4 Z-Hpg-OH >98% 1 G 16000
CX54783-500MG Boc-D-homopropargylglycine (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid Not available 227.26 C11 H17 N O4 Boc-D-Hpg-OH >98% 500 MG 9800
CX54783-1G Boc-D-homopropargylglycine (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid Not available 227.26 C11 H17 N O4 Boc-D-Hpg-OH >98% 1 G 16000
CX14845-500MG Cbz-D-homopropargylglycine (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid Not available 261.27 C14 H15 N O4 Z-D-Hpg-OH >98% 500 MG 9800
CX14845-1G Cbz-D-homopropargylglycine (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid Not available 261.27 C14 H15 N O4 Z-D-Hpg-OH >98% 1 G 16000
CX87818-500MG Fmoc-D-homopropargylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid Not available 349.38 C21 H19 N O4 Fmoc-D-Hpg-OH >97% 500 MG 11200
CX87818-1G Fmoc-D-homopropargylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid Not available 349.38 C21 H19 N O4 Fmoc-D-Hpg-OH >97% 1 G 18400
CX57816-500MG Fmoc-L-bishomopropargylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid Not available 363.41 C22 H21 N O4 Fmoc-Bpg-OH >97% 500 MG 10400
CX57816-1G Fmoc-L-bishomopropargylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid Not available 363.41 C22 H21 N O4 Fmoc-Bpg-OH >97% 1 G 16800
CX32424-200MG D-bishomopropargylglycine (R)-2-aminohept-6-ynoic acid 211054-03-4 141.17 C7 H11 N O2 H-D-Bpg-OH >98% 200 MG 4400
CX32424-500MG D-bishomopropargylglycine (R)-2-aminohept-6-ynoic acid 211054-03-4 141.17 C7 H11 N O2 H-D-Bpg-OH >98% 500 MG 9000
CX32424-1G D-bishomopropargylglycine (R)-2-aminohept-6-ynoic acid 211054-03-4 141.17 C7 H11 N O2 H-D-Bpg-OH >98% 1 G 14600
CX80846-500MG Fmoc-D-bishomopropargylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid Not available 363.41 C22 H21 N O4 Fmoc-D-Bpg-OH >97% 500 MG 10400
CX80846-1G Fmoc-D-bishomopropargylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid Not available 363.41 C22 H21 N O4 Fmoc-D-Bpg-OH >97% 1 G 16800
CX52977-1G (S)-Boc-beta3-phenylalanine (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid 103365-47-5 265.30 C14 H19 N O4   >98% 1 G 2200
CX52977-2G (S)-Boc-beta3-phenylalanine (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid 103365-47-5 265.30 C14 H19 N O4   >98% 2 G 3800
CX52977-5G (S)-Boc-beta3-phenylalanine (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid 103365-47-5 265.30 C14 H19 N O4   >98% 5 G 7200
CX79659-1G (S)-Cbz-beta3-phenylalanine (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid 14441-08-8 299.32 C17 H17 N O4   >98% 1 G 2200
CX79659-2G (S)-Cbz-beta3-phenylalanine (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid 14441-08-8 299.32 C17 H17 N O4   >98% 2 G 3800
CX79659-5G (S)-Cbz-beta3-phenylalanine (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid 14441-08-8 299.32 C17 H17 N O4   >98% 5 G 7200
CX56872-1G (S)-Fmoc-beta3-phenylalanine (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid 209252-15-3 387.43 C24 H21 N O4   >98% 1 G 2600
CX56872-2G (S)-Fmoc-beta3-phenylalanine (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid 209252-15-3 387.43 C24 H21 N O4   >98% 2 G 4400
CX56872-5G (S)-Fmoc-beta3-phenylalanine (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid 209252-15-3 387.43 C24 H21 N O4   >98% 5 G 8600
CX44048-1G Boc-D-tert-leucine (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid 124655-17-0 231.29 C11 H21 N O4 Boc-D-tert-Leu-OH >98% 1 G 2200
CX44048-2G Boc-D-tert-leucine (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid 124655-17-0 231.29 C11 H21 N O4 Boc-D-tert-Leu-OH >98% 2 G 3800
CX44048-5G Boc-D-tert-leucine (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid 124655-17-0 231.29 C11 H21 N O4 Boc-D-tert-Leu-OH >98% 5 G 7200
CX22855-1G Fmoc-D-tert-leucine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid 198543-64-5 353.41 C21 H23 N O4 Fmoc-D-tert-Leu-OH >97% 1 G 2600
CX22855-2G Fmoc-D-tert-leucine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid 198543-64-5 353.41 C21 H23 N O4 Fmoc-D-tert-Leu-OH >97% 2 G 4400
CX22855-5G Fmoc-D-tert-leucine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid 198543-64-5 353.41 C21 H23 N O4 Fmoc-D-tert-Leu-OH >97% 5 G 8600
CX28901-1G (S)-Boc-alpha-methyl-phenylglycine (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid 802541-88-4 265.30 C14 H19 N O4 (S)-Boc-Mpg-OH >98% 1 G 9000
CX28901-2G (S)-Boc-alpha-methyl-phenylglycine (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid 802541-88-4 265.30 C14 H19 N O4 (S)-Boc-Mpg-OH >98% 2 G 14800
CX28344-1G (S)-Fmoc-alpha-methyl-phenylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid 881921-11-5 387.43 C24 H21 N O4 (S)-Fmoc-Mpg-OH >98% 1 G 10400
CX28344-2G (S)-Fmoc-alpha-methyl-phenylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid 881921-11-5 387.43 C24 H21 N O4 (S)-Fmoc-Mpg-OH >98% 2 G 17200
CX93005-1G Fmoc-L-azidoalanine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid 684270-46-0 352.34 C18 H16 N4 O4 Fmoc-Aza-OH >98% 1 G 3400
CX93005-5G Fmoc-L-azidoalanine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid 684270-46-0 352.34 C18 H16 N4 O4 Fmoc-Aza-OH >98% 5 G 12000
CX90286-200MG bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate 90852-19-0 340.29 C12 H16 N6 O6 2-DOS diazide triacetate >98% 200 MG 4200
CX90286-500MG bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate 90852-19-0 340.29 C12 H16 N6 O6 2-DOS diazide triacetate >98% 500 MG 8800
CX90286-1G bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate 90852-19-0 340.29 C12 H16 N6 O6 2-DOS diazide triacetate >98% 1 G 15200
CX44848-200MG (R)-4-oxopipecolic acid ethylene acetal (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid Not available 187.19 C8 H13 N O4   >98% 200 MG 5200
CX44848-500MG (R)-4-oxopipecolic acid ethylene acetal (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid Not available 187.19 C8 H13 N O4   >98% 500 MG 11000
CX44848-1G (R)-4-oxopipecolic acid ethylene acetal (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid Not available 187.19 C8 H13 N O4   >98% 1 G 19200
CX45124-500MG (R)-alpha-methyl-phenylglycine (R)-2-amino-2-phenylpropanoic acid 29738-09-8 165.19 C9 H11 N O2 (R)-H-Mpg-OH >98% 500 MG 6200
CX45124-1G (R)-alpha-methyl-phenylglycine (R)-2-amino-2-phenylpropanoic acid 29738-09-8 165.19 C9 H11 N O2 (R)-H-Mpg-OH >98% 1 G 10400
CX45124-2G (R)-alpha-methyl-phenylglycine (R)-2-amino-2-phenylpropanoic acid 29738-09-8 165.19 C9 H11 N O2 (R)-H-Mpg-OH >98% 2 G 17200
CX43844-1G L-azidoleucine CHA salt cyclohexanaminium (S)-2-azido-4-methylpentanoate Not available 256.34 C12 H24 N4 O2 N3-Leu-OH · CHA >98% 1 G 2800
CX43844-5G L-azidoleucine CHA salt cyclohexanaminium (S)-2-azido-4-methylpentanoate Not available 256.34 C12 H24 N4 O2 N3-Leu-OH · CHA >98% 5 G 10600
CX66793-1G L-azidovaline CHA salt cyclohexanaminium (S)-2-azido-3-methylbutanoate Not available 242.32 C11 H22 N4 O2 N3-Val-OH · CHA >98% 1 G 2600
CX66793-5G L-azidovaline CHA salt cyclohexanaminium (S)-2-azido-3-methylbutanoate Not available 242.32 C11 H22 N4 O2 N3-Val-OH · CHA >98% 5 G 9800
CX90285-1G L-azidotryptophan CHA salt cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate Not available 329.40 C17 H23 N5 O2 N3-Trp-OH · CHA >98% 1 G 2400
CX90285-5G L-azidotryptophan CHA salt cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate Not available 329.40 C17 H23 N5 O2 N3-Trp-OH · CHA >98% 5 G 9000
CX32182-1G L-azidoalanine CHA salt cyclohexanaminium (S)-2-azidopropanoate Not available 214.26 C9 H18 N4 O2 N3-Ala-OH · CHA >98% 1 G 2800
CX32182-5G L-azidoalanine CHA salt cyclohexanaminium (S)-2-azidopropanoate Not available 214.26 C9 H18 N4 O2 N3-Ala-OH · CHA >98% 5 G 10600
CX33085-1G L-azidophenylalanine CHA salt cyclohexanaminium (S)-2-azido-3-phenylpropanoate Not available 290.36 C15 H22 N4 O2 N3-Phe-OH · CHA >98% 1 G 2400
CX33085-5G L-azidophenylalanine CHA salt cyclohexanaminium (S)-2-azido-3-phenylpropanoate Not available 290.36 C15 H22 N4 O2 N3-Phe-OH · CHA >98% 5 G 9000
CX37236-1G L-azidoisoleucine CHA salt cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate Not available 256.34 C12 H24 N4 O2 N3-Ile-OH · CHA >98% 1 G 2800
CX37236-5G L-azidoisoleucine CHA salt cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate Not available 256.34 C12 H24 N4 O2 N3-Ile-OH · CHA >98% 5 G 10600
CX81236-1G L-azidotyrosine CHA salt cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate Not available 306.36 C15 H22 N4 O3 N3-Tyr-OH · CHA >97% 1 G 2800
CX81236-5G L-azidotyrosine CHA salt cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate Not available 306.36 C15 H22 N4 O3 N3-Tyr-OH · CHA >97% 5 G 10600
CX84940-1G L-azidomethionine CHA salt cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate Not available 274.38 C11 H22 N4 O2 S N3-Met-OH · CHA >98% 1 G 2600
CX84940-5G L-azidomethionine CHA salt cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate Not available 274.38 C11 H22 N4 O2 S N3-Met-OH · CHA >98% 5 G 9800
CX81456-200MG (S)-5-oxopipecolic acid ethylene acetal (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid Not available 187.19 C8 H13 N O4   >98% 200 MG 5200
CX81456-500MG (S)-5-oxopipecolic acid ethylene acetal (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid Not available 187.19 C8 H13 N O4   >98% 500 MG 11000
CX81456-1G (S)-5-oxopipecolic acid ethylene acetal (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid Not available 187.19 C8 H13 N O4   >98% 1 G 19200
CX80632-1G L-azidothreonine tert-butyl ether CHA salt cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate Not available 300.40 C14 H28 N4 O3 N3-Thr(OtBu)-OH · CHA >98% 1 G 2800
CX80632-5G L-azidothreonine tert-butyl ether CHA salt cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate Not available 300.40 C14 H28 N4 O3 N3-Thr(OtBu)-OH · CHA >98% 5 G 10600
CX59871-1G L-azidoserine CHA salt cyclohexanaminium (S)-2-azido-3-hydroxypropanoate Not available 230.26 C9 H18 N4 O3 N3-Ser-OH · CHA >98% 1 G 2600
CX59871-5G L-azidoserine CHA salt cyclohexanaminium (S)-2-azido-3-hydroxypropanoate Not available 230.26 C9 H18 N4 O3 N3-Ser-OH · CHA >98% 5 G 9800
CX20625-1G L-azidoaspartic acid mono-tert-butyl ester CHA salt cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate Not available 314.38 C14 H26 N4 O4 N3-Asp(OtBu)-OH · CHA >98% 1 G 2600
CX20625-5G L-azidoaspartic acid mono-tert-butyl ester CHA salt cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate Not available 314.38 C14 H26 N4 O4 N3-Asp(OtBu)-OH · CHA >98% 5 G 9800
CX24163-1G L-azidoglutamic acid mono-tert-butyl ester CHA salt cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate Not available 328.41 C15 H28 N4 O4 N3-Glu(OtBu)-OH · CHA >98% 1 G 2800
CX24163-5G L-azidoglutamic acid mono-tert-butyl ester CHA salt cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate Not available 328.41 C15 H28 N4 O4 N3-Glu(OtBu)-OH · CHA >98% 5 G 10600
CX68680-1G L-azidotyrosine tert-butyl ether CHA salt cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate Not available 362.47 C19 H30 N4 O3 N3-Tyr(OtBu)-OH · CHA >98% 1 G 2800
CX68680-5G L-azidotyrosine tert-butyl ether CHA salt cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate Not available 362.47 C19 H30 N4 O3 N3-Tyr(OtBu)-OH · CHA >98% 5 G 10600
CX55921-1G L-azidoserine tert-butyl ether CHA salt cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate Not available 286.37 C13 H26 N4 O3 N3-Ser(OtBu)-OH · CHA >98% 1 G 2800
CX55921-5G L-azidoserine tert-butyl ether CHA salt cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate Not available 286.37 C13 H26 N4 O3 N3-Ser(OtBu)-OH · CHA >98% 5 G 10600
CX54776-200MG (S)-4-oxopipecolic acid ethylene acetal (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid 356073-54-6 187.19 C8 H13 N O4   >98% 200 MG 5200
CX54776-500MG (S)-4-oxopipecolic acid ethylene acetal (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid 356073-54-6 187.19 C8 H13 N O4   >98% 500 MG 11000
CX54776-1G (S)-4-oxopipecolic acid ethylene acetal (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid 356073-54-6 187.19 C8 H13 N O4   >98% 1 G 19200
CX46058-1G D-azidovaline CHA salt cyclohexanaminium (R)-2-azido-3-methylbutanoate Not available 242.32 C11 H22 N4 O2 N3-D-Val-OH · CHA >98% 1 G 3000
CX46058-5G D-azidovaline CHA salt cyclohexanaminium (R)-2-azido-3-methylbutanoate Not available 242.32 C11 H22 N4 O2 N3-D-Val-OH · CHA >98% 5 G 11200
CX44158-1G D-azidoalanine CHA salt cyclohexanaminium (R)-2-azidopropanoate Not available 214.26 C9 H18 N4 O2 N3-D-Ala-OH · CHA >98% 1 G 3400
CX44158-5G D-azidoalanine CHA salt cyclohexanaminium (R)-2-azidopropanoate Not available 214.26 C9 H18 N4 O2 N3-D-Ala-OH · CHA >98% 5 G 12800
CX27954-1G D-azidophenylalanine CHA salt cyclohexanaminium (R)-2-azido-3-phenylpropanoate Not available 290.36 C15 H22 N4 O2 D-N3-Phe-OH · CHA >98% 1 G 2800
CX27954-5G D-azidophenylalanine CHA salt cyclohexanaminium (R)-2-azido-3-phenylpropanoate Not available 290.36 C15 H22 N4 O2 D-N3-Phe-OH · CHA >98% 5 G 10600
CX56656-1G D-azidomethionine CHA salt cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate Not available 274.38 C11 H22 N4 O2 S N3-D-Met-OH · CHA >98% 1 G 2800
CX56656-5G D-azidomethionine CHA salt cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate Not available 274.38 C11 H22 N4 O2 S N3-D-Met-OH · CHA >98% 5 G 10600
CX16129-500MG Cbz-L-bishomopropargylglycine CHA salt cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate Not available 374.47 C21 H30 N2 O4 Z-Bpg-OH · CHA >98% 500 MG 9000
CX16129-1G Cbz-L-bishomopropargylglycine CHA salt cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate Not available 374.47 C21 H30 N2 O4 Z-Bpg-OH · CHA >98% 1 G 14600
CX65817-1G (S)-Cbz-alpha-methyl-phenylglycine CHA salt cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate Not available 398.50 C23 H30 N2 O4 (S)-Cbz-Mpg-OH · CHA >98% 1 G 9000
CX65817-2G (S)-Cbz-alpha-methyl-phenylglycine CHA salt cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate Not available 398.50 C23 H30 N2 O4 (S)-Cbz-Mpg-OH · CHA >98% 2 G 14800
CX19691-500MG Boc-D-bishomopropargylglycine CHA salt cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate Not available 340.46 C18 H32 N2 O4 Boc-D-Bpg-OH · CHA >98% 500 MG 9000
CX19691-1G Boc-D-bishomopropargylglycine CHA salt cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate Not available 340.46 C18 H32 N2 O4 Boc-D-Bpg-OH · CHA >98% 1 G 14600
CX59796-500MG Boc-L-bishomopropargylglycine CHA salt cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate Not available 340.46 C18 H32 N2 O4 Boc-Bpg-OH · CHA >98% 500 MG 9000
CX59796-1G Boc-L-bishomopropargylglycine CHA salt cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate Not available 340.46 C18 H32 N2 O4 Boc-Bpg-OH · CHA >98% 1 G 14600
CX79723-1G (R)-Fmoc-alpha-methyl-phenylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid 881920-86-1 387.43 C24 H21 N O4 (R)-Fmoc-Mpg-OH >98% 1 G 12000
CX79723-2G (R)-Fmoc-alpha-methyl-phenylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid 881920-86-1 387.43 C24 H21 N O4 (R)-Fmoc-Mpg-OH >98% 2 G 19800
CX32015-1G Cbz-D-tert-leucine CHA salt cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate Not available 364.48 C20 H32 N2 O4 Z-D-tert-Leu-OH · CHA >98% 1 G 2200
CX32015-2G Cbz-D-tert-leucine CHA salt cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate Not available 364.48 C20 H32 N2 O4 Z-D-tert-Leu-OH · CHA >98% 2 G 3800
CX32015-5G Cbz-D-tert-leucine CHA salt cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate Not available 364.48 C20 H32 N2 O4 Z-D-tert-Leu-OH · CHA >98% 5 G 7200
CX81118-1G Fmoc-L-azidolysine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid 159610-89-6 394.42 C21 H22 N4 O4 Fmoc-Lys(N2)-OH >98% 1 G 3400
CX81118-5G Fmoc-L-azidolysine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid 159610-89-6 394.42 C21 H22 N4 O4 Fmoc-Lys(N2)-OH >98% 5 G 12000
CX19587-500MG Cbz-D-bishomopropargylglycine CHA salt cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate Not available 374.47 C21 H30 N2 O4 Z-D-Bpg-OH · CHA >98% 500 MG 9000
CX19587-1G Cbz-D-bishomopropargylglycine CHA salt cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate Not available 374.47 C21 H30 N2 O4 Z-D-Bpg-OH · CHA >98% 1 G 14600
CX28021-500MG H-Arg(Boc)2-pNA (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate Not available 494.54 C22 H34 N6 O7   >97% 500 MG 6000
CX28021-1G H-Arg(Boc)2-pNA (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate Not available 494.54 C22 H34 N6 O7   >97% 1 G 11000
CX72798-1G D-azidoaspartic acid mono-tert-butyl ester CHA salt cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate Not available 314.38 C14 H26 N4 O4 N3-D-Asp(OtBu)-OH · CHA >98% 1 G 6200
CX72798-5G D-azidoaspartic acid mono-tert-butyl ester CHA salt cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate Not available 314.38 C14 H26 N4 O4 N3-D-Asp(OtBu)-OH · CHA >98% 5 G 23400
CX93516-1G D-azidoglutamic acid mono-tert-butyl ester CHA salt cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate Not available 328.41 C15 H28 N4 O4 N3-D-Glu(OtBu)-OH · CHA >98% 1 G 5200
CX93516-5G D-azidoglutamic acid mono-tert-butyl ester CHA salt cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate Not available 328.41 C15 H28 N4 O4 N3-D-Glu(OtBu)-OH · CHA >98% 5 G 19600
CX76762-1G D-azidoleucine CHA salt cyclohexanaminium (R)-2-azido-4-methylpentanoate Not available 256.34 C12 H24 N4 O2 N3-D-Leu-OH · CHA >98% 1 G 3000
CX76762-5G D-azidoleucine CHA salt cyclohexanaminium (R)-2-azido-4-methylpentanoate Not available 256.34 C12 H24 N4 O2 N3-D-Leu-OH · CHA >98% 5 G 11200
CX53333-1G D-azidoisoleucine CHA salt cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate Not available 256.34 C12 H24 N4 O2 N3-D-Ile-OH · CHA >98% 1 G 9200
CX53333-2G D-azidoisoleucine CHA salt cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate Not available 256.34 C12 H24 N4 O2 N3-D-Ile-OH · CHA >98% 2 G 16400
CX83245-1G D-azidotyrosine tert-butyl ether CHA salt cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate Not available 362.47 C19 H30 N4 O3 N3-D-Tyr(OtBu)-OH · CHA >98% 1 G 5400
CX83245-5G D-azidotyrosine tert-butyl ether CHA salt cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate Not available 362.47 C19 H30 N4 O3 N3-D-Tyr(OtBu)-OH · CHA >98% 5 G 20400
CX13425-1G D-azidoserine tert-butyl ether CHA salt cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate Not available 286.37 C13 H26 N4 O3 N3-D-Ser(OtBu)-OH · CHA >98% 1 G 7200
CX13425-5G D-azidoserine tert-butyl ether CHA salt cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate Not available 286.37 C13 H26 N4 O3 N3-D-Ser(OtBu)-OH · CHA >98% 5 G 27200
CX29937-1G D-azidothreonine tert-butyl ether CHA salt cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate Not available 300.40 C14 H28 N4 O3 N3-D-Thr(OtBu)-OH · CHA >98% 1 G 6400
CX29937-5G D-azidothreonine tert-butyl ether CHA salt cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate Not available 300.40 C14 H28 N4 O3 N3-D-Thr(OtBu)-OH · CHA >98% 5 G 24200
CX85233-1G L-azidothreonine CHA salt cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate Not available 244.29 C10 H20 N4 O3 N3-Thr-OH · CHA >98% 1 G 2600
CX85233-5G L-azidothreonine CHA salt cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate Not available 244.29 C10 H20 N4 O3 N3-Thr-OH · CHA >98% 5 G 9800
CX37313-1G D-azidothreonine CHA salt cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate Not available 244.29 C10 H20 N4 O3 N3-D-Thr-OH · CHA >98% 1 G 3000
CX37313-5G D-azidothreonine CHA salt cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate Not available 244.29 C10 H20 N4 O3 N3-D-Thr-OH · CHA >98% 5 G 11200
CX95405-1G D-azidoserine CHA salt cyclohexanaminium (R)-2-azido-3-hydroxypropanoate Not available 230.26 C9 H18 N4 O3 N3-D-Ser-OH · CHA >98% 1 G 3200
CX95405-5G D-azidoserine CHA salt cyclohexanaminium (R)-2-azido-3-hydroxypropanoate Not available 230.26 C9 H18 N4 O3 N3-D-Ser-OH · CHA >98% 5 G 12000
CX57717-1G L-azidoglutamine DCHA salt dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate Not available 353.46 C17 H31 N5 O3 N3-Gln-OH · DCHA >98% 1 G 2600
CX57717-5G L-azidoglutamine DCHA salt dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate Not available 353.46 C17 H31 N5 O3 N3-Gln-OH · DCHA >98% 5 G 9800
CX79807-1G D-azidoglutamine DCHA salt dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate Not available 353.46 C17 H31 N5 O3 N3-D-Gln-OH · DCHA >98% 1 G 3200
CX79807-5G D-azidoglutamine DCHA salt dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate Not available 353.46 C17 H31 N5 O3 N3-D-Gln-OH · DCHA >98% 5 G 12000
CX94556-1G L-azidoasparagine DCHA salt dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate 79410-49-4 339.43 C16 H29 N5 O3 N3-Asn-OH · DCHA >98% 1 G 3200
CX94556-5G L-azidoasparagine DCHA salt dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate 79410-49-4 339.43 C16 H29 N5 O3 N3-Asn-OH · DCHA >98% 5 G 12000
CX83100-1G D-azidoasparagine DCHA salt dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate Not available 339.43 C16 H29 N5 O3 N3-D-Asn-OH · DCHA >98% 1 G 4000
CX83100-5G D-azidoasparagine DCHA salt dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate Not available 339.43 C16 H29 N5 O3 N3-D-Asn-OH · DCHA >98% 5 G 15000
CX48141-1G D-azidotryptophan CHA salt cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate Not available 329.40 C17 H23 N5 O2 N3-D-Trp-OH · CHA >98% 1 G 2600
CX48141-5G D-azidotryptophan CHA salt cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate Not available 329.40 C17 H23 N5 O2 N3-D-Trp-OH · CHA >98% 5 G 9800
CX93426-1G N-im-trityl-L-azidohistidine CHA salt cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate Not available 522.64 C31 H34 N6 O2 N3-His(Trt)-OH · CHA >98% 1 G 4000
CX93426-5G N-im-trityl-L-azidohistidine CHA salt cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate Not available 522.64 C31 H34 N6 O2 N3-His(Trt)-OH · CHA >98% 5 G 15000
CX24279-1G D-azidotyrosine CHA salt cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate Not available 306.36 C15 H22 N4 O3 N3-D-Tyr-OH · CHA >98% 1 G 3600
CX24279-5G D-azidotyrosine CHA salt cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate Not available 306.36 C15 H22 N4 O3 N3-D-Tyr-OH · CHA >98% 5 G 13600
CX78063-1G L-azido-tert-leucine CHA salt cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate Not available 256.34 C12 H24 N4 O2 N3-tert-Leu-OH · CHA >98% 1 G 2800
CX78063-5G L-azido-tert-leucine CHA salt cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate Not available 256.34 C12 H24 N4 O2 N3-tert-Leu-OH · CHA >98% 5 G 10600
CX30547-1G D-azido-tert-leucine CHA salt cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate Not available 256.34 C12 H24 N4 O2 N3-D-tert-Leu-OH · CHA >98% 1 G 6600
CX30547-5G D-azido-tert-leucine CHA salt cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate Not available 256.34 C12 H24 N4 O2 N3-D-tert-Leu-OH · CHA >98% 5 G 25000
CX78942-1G L-azidoallylglycine CHA salt cyclohexanaminium (S)-2-azidopent-4-enoate Not available 240.30 C11 H20 N4 O2 N3-Alg-OH · CHA >98% 1 G 5600
CX78942-5G L-azidoallylglycine CHA salt cyclohexanaminium (S)-2-azidopent-4-enoate Not available 240.30 C11 H20 N4 O2 N3-Alg-OH · CHA >98% 5 G 21200
CX61332-1G D-azidoallylglycine CHA salt cyclohexanaminium (R)-2-azidopent-4-enoate Not available 240.30 C11 H20 N4 O2 N3-D-Alg-OH · CHA >98% 1 G 9000
CX61332-2G D-azidoallylglycine CHA salt cyclohexanaminium (R)-2-azidopent-4-enoate Not available 240.30 C11 H20 N4 O2 N3-D-Alg-OH · CHA >98% 2 G 16000
CX56925-1G Ng-Pmc-L-azidoarginine (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid Not available 466.55 C20 H30 N6 O5 S Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine >95% 1 G 4000
CX56925-5G Ng-Pmc-L-azidoarginine (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid Not available 466.55 C20 H30 N6 O5 S Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine >95% 5 G 15000
CX22361-1G (S)-azido-alpha-methyl-phenylglycine CHA salt cyclohexanaminium (S)-2-azido-2-phenylpropanoate Not available 290.36 C15 H22 N4 O2 (S)-N3-Mpg-OH · CHA >98% 1 G 9000
CX22361-2G (S)-azido-alpha-methyl-phenylglycine CHA salt cyclohexanaminium (S)-2-azido-2-phenylpropanoate Not available 290.36 C15 H22 N4 O2 (S)-N3-Mpg-OH · CHA >98% 2 G 14800
CX52265-1G (R)-azido-alpha-methylphenylglycine CHA salt cyclohexanaminium (R)-2-azido-2-phenylpropanoate Not available 290.36 C15 H22 N4 O2 (R)-N3-Mpg-OH · CHA >98% 1 G 10400
CX52265-2G (R)-azido-alpha-methylphenylglycine CHA salt cyclohexanaminium (R)-2-azido-2-phenylpropanoate Not available 290.36 C15 H22 N4 O2 (R)-N3-Mpg-OH · CHA >98% 2 G 17200
CX71813-1G S-Trityl-L-azidocysteine CHA salt cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate Not available 488.64 C28 H32 N4 O2 S N3-Cys(Trt)-OH · CHA >98% 1 G 3000
CX71813-5G S-Trityl-L-azidocysteine CHA salt cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate Not available 488.64 C28 H32 N4 O2 S N3-Cys(Trt)-OH · CHA >98% 5 G 11200
CX40608-5G 6-azidohexanoic acid 6-azidohexanoic acid 79598-53-1 157.17 C6 H11 N3 O2   >98% 5 G 6000
CX40608-10G 6-azidohexanoic acid 6-azidohexanoic acid 79598-53-1 157.17 C6 H11 N3 O2   >98% 10 G 11000
CX23053-500MG (S)-bishomopropargylglycinol hydrochloride (S)-2-aminohept-6-yn-1-ol hydrochloride Not available 163.65 C7 H14 Cl N O   >98% 500 MG 10400
CX23053-1G (S)-bishomopropargylglycinol hydrochloride (S)-2-aminohept-6-yn-1-ol hydrochloride Not available 163.65 C7 H14 Cl N O   >98% 1 G 17200
CX63523-500MG (R)-bishomopropargylglycinol hydrochloride (R)-2-aminohept-6-yn-1-ol hydrochloride Not available 163.65 C7 H14 Cl N O   >98% 500 MG 10400
CX63523-1G (R)-bishomopropargylglycinol hydrochloride (R)-2-aminohept-6-yn-1-ol hydrochloride Not available 163.65 C7 H14 Cl N O   >98% 1 G 17200
CX69091-500MG (R)-homopropargylglycinol hydrochloride (R)-2-aminohex-5-yn-1-ol hydrochloride Not available 149.62 C6 H12 Cl N O   >98% 500 MG 11000
CX69091-1G (R)-homopropargylglycinol hydrochloride (R)-2-aminohex-5-yn-1-ol hydrochloride Not available 149.62 C6 H12 Cl N O   >98% 1 G 17800
CX76358-500MG (S)-homopropargylglycinol hydrochloride (S)-2-aminohex-5-yn-1-ol hydrochloride Not available 149.62 C6 H12 Cl N O   >98% 500 MG 11000
CX76358-1G (S)-homopropargylglycinol hydrochloride (S)-2-aminohex-5-yn-1-ol hydrochloride Not available 149.62 C6 H12 Cl N O   >98% 1 G 17800
CX55029-2MG cereulide cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 Not available 1153.40 C57 H96 N6 O18   >95% 2 MG 12000
CX55029-5MG cereulide cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 Not available 1153.40 C57 H96 N6 O18   >95% 5 MG 24000
CX45120-1G H-Orn(Boc)-pNA (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate Not available 352.39 C16 H24 N4 O5   >98% 1 G 4000
CX45120-2G H-Orn(Boc)-pNA (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate Not available 352.39 C16 H24 N4 O5   >98% 2 G 9000
CX45120-5G H-Orn(Boc)-pNA (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate Not available 352.39 C16 H24 N4 O5   >98% 5 G 15000
CX57163-2MG 13C6-cereulide cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 Not available 1159.36 C51 13 C6 H96 N6 O18   >95% 2 MG 24000
CX64158-1G Fmoc-Orn-pNA · HCl (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride Not available 510.97 C26 H27 Cl N4 O5 Fmoc-Orn-pNA HCl salt >98% 1 G 4000
CX64158-2G Fmoc-Orn-pNA · HCl (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride Not available 510.97 C26 H27 Cl N4 O5 Fmoc-Orn-pNA HCl salt >98% 2 G 7200
CX64158-5G Fmoc-Orn-pNA · HCl (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride Not available 510.97 C26 H27 Cl N4 O5 Fmoc-Orn-pNA HCl salt >98% 5 G 15000
CX80044-250MG Bis(H-Orn(Boc))-rhodamine 110 Bis(H-Orn(Boc))-rhodamine Not available 758.86 C40 H50 N6 O9   >95% 250 MG 7600
CX80044-500MG Bis(H-Orn(Boc))-rhodamine 110 Bis(H-Orn(Boc))-rhodamine Not available 758.86 C40 H50 N6 O9   >95% 500 MG 14000
CX80044-1G Bis(H-Orn(Boc))-rhodamine 110 Bis(H-Orn(Boc))-rhodamine Not available 758.86 C40 H50 N6 O9   >95% 1 G 25000
CX67830-250MG Bis(H-Arg(Boc)2)-rhodamine 110 Bis(H-Arg(Boc)2)-rhodamine Not available 1043.17 C52 H70 N10 O13   >95% 250 MG 7800
CX67830-500MG Bis(H-Arg(Boc)2)-rhodamine 110 Bis(H-Arg(Boc)2)-rhodamine Not available 1043.17 C52 H70 N10 O13   >95% 500 MG 14400
CX67830-1G Bis(H-Arg(Boc)2)-rhodamine 110 Bis(H-Arg(Boc)2)-rhodamine Not available 1043.17 C52 H70 N10 O13   >95% 1 G 26000
CX18326-1G Fmoc-Orn-AMC · HCl (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride Not available 548.03 C30 H30 Cl N3 O5   >98% 1 G 5000
CX18326-2G Fmoc-Orn-AMC · HCl (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride Not available 548.03 C30 H30 Cl N3 O5   >98% 2 G 9000
CX18326-5G Fmoc-Orn-AMC · HCl (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride Not available 548.03 C30 H30 Cl N3 O5   >98% 5 G 19000
CX59077-1G H-Orn(Boc)-AMC (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate Not available 389.45 C20 H27 N3 O5   >98% 1 G 6000
CX59077-2G H-Orn(Boc)-AMC (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate Not available 389.45 C20 H27 N3 O5   >98% 2 G 10800
CX59077-5G H-Orn(Boc)-AMC (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate Not available 389.45 C20 H27 N3 O5   >98% 5 G 22000
CX48623-1G H-Lys(Boc)-AMC (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate 222037-62-9 403.47 C21 H29 N3 O5   >98% 1 G 5000
CX48623-2G H-Lys(Boc)-AMC (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate 222037-62-9 403.47 C21 H29 N3 O5   >98% 2 G 9000
CX48623-5G H-Lys(Boc)-AMC (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate 222037-62-9 403.47 C21 H29 N3 O5   >98% 5 G 19000
CX55361-500MG H-Arg(Boc)2-AMC H-Arg(Boc)2-AMC Not available 531.60 C26 H37 N5 O7   >97% 500 MG 6000
CX55361-1G H-Arg(Boc)2-AMC H-Arg(Boc)2-AMC Not available 531.60 C26 H37 N5 O7   >97% 1 G 10800
CX84944-1G Fmoc-Lys-AMC · HCl (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride Not available 562.06 C31 H32 Cl N3 O5   >98% 1 G 4000
CX84944-2G Fmoc-Lys-AMC · HCl (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride Not available 562.06 C31 H32 Cl N3 O5   >98% 2 G 7200
CX84944-5G Fmoc-Lys-AMC · HCl (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride Not available 562.06 C31 H32 Cl N3 O5   >98% 5 G 15000
CX69359-5G 4-azidobutyric acid 4-azidobutanoic acid 54447-68-6 129.12 C4 H7 N3 O2 gamma-azidobutyric acid >98% 5 G 6000
CX69359-10G 4-azidobutyric acid 4-azidobutanoic acid 54447-68-6 129.12 C4 H7 N3 O2 gamma-azidobutyric acid >98% 10 G 11000
CX31309-5G 5-azidovaleric acid 5-azidopentanoic acid 79583-98-5 143.14 C5 H9 N3 O2 delta-azidovaleric acid >98% 5 G 6600
CX31309-10G 5-azidovaleric acid 5-azidopentanoic acid 79583-98-5 143.14 C5 H9 N3 O2 delta-azidovaleric acid >98% 10 G 11800
CX98490-5G 7-azidoheptanoic acid 7-azidoheptanoic acid 135920-28-4 171.20 C7 H13 N3 O2   >98% 5 G 6000
CX98490-10G 7-azidoheptanoic acid 7-azidoheptanoic acid 135920-28-4 171.20 C7 H13 N3 O2   >98% 10 G 11000
CX65527-1G 6-methylcyclohex-1-enecarboxylic acid 6-methylcyclohex-1-enecarboxylic acid 5726-56-7 140.18 C8 H12 O2   >98% 1 G 2800
CX65527-5G 6-methylcyclohex-1-enecarboxylic acid 6-methylcyclohex-1-enecarboxylic acid 5726-56-7 140.18 C8 H12 O2   >98% 5 G 10600
CX65527-10G 6-methylcyclohex-1-enecarboxylic acid 6-methylcyclohex-1-enecarboxylic acid 5726-56-7 140.18 C8 H12 O2   >98% 10 G 17000
CX61074-200MG (S)-beta2-homoalanine HCl salt (S)-3-amino-2-methylpropanoic acid hydrochloride Not available 139.58 C4 H10 Cl N O2 (S)-beta2-hAla-OH · HCl >98% 200 MG 4800
CX61074-500MG (S)-beta2-homoalanine HCl salt (S)-3-amino-2-methylpropanoic acid hydrochloride Not available 139.58 C4 H10 Cl N O2 (S)-beta2-hAla-OH · HCl >98% 500 MG 9800
CX61074-1G (S)-beta2-homoalanine HCl salt (S)-3-amino-2-methylpropanoic acid hydrochloride Not available 139.58 C4 H10 Cl N O2 (S)-beta2-hAla-OH · HCl >98% 1 G 16000
CX39389-200MG (R)-beta2-homoalanine HCl salt (R)-3-amino-2-methylpropanoic acid hydrochloride Not available 139.58 C4 H10 Cl N O2 (R)-beta2-hAla-OH · HCl >98% 200 MG 4800
CX39389-500MG (R)-beta2-homoalanine HCl salt (R)-3-amino-2-methylpropanoic acid hydrochloride Not available 139.58 C4 H10 Cl N O2 (R)-beta2-hAla-OH · HCl >98% 500 MG 9800
CX39389-1G (R)-beta2-homoalanine HCl salt (R)-3-amino-2-methylpropanoic acid hydrochloride Not available 139.58 C4 H10 Cl N O2 (R)-beta2-hAla-OH · HCl >98% 1 G 16000
CX80391-200MG (R)-beta2-homoleucine HCl salt (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride Not available 181.66 C7 H16 Cl N O2 (R)-beta2-hLeu-OH · HCl >98% 200 MG 4800
CX80391-500MG (R)-beta2-homoleucine HCl salt (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride Not available 181.66 C7 H16 Cl N O2 (R)-beta2-hLeu-OH · HCl >98% 500 MG 9800
CX80391-1G (R)-beta2-homoleucine HCl salt (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride Not available 181.66 C7 H16 Cl N O2 (R)-beta2-hLeu-OH · HCl >98% 1 G 16000
CX82876-200MG (R)-beta2-homovaline HCl salt (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride Not available 167.63 C6 H14 Cl N O2 (R)-beta2-hVal-OH · HCl >98% 200 MG 4800
CX82876-500MG (R)-beta2-homovaline HCl salt (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride Not available 167.63 C6 H14 Cl N O2 (R)-beta2-hVal-OH · HCl >98% 500 MG 9800
CX82876-1G (R)-beta2-homovaline HCl salt (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride Not available 167.63 C6 H14 Cl N O2 (R)-beta2-hVal-OH · HCl >98% 1 G 16000
CX93488-1MG (±)-sorgolactone (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one Not available 316.35 C18 H20 O5 racemic sorgolactone >98% 1 MG 4000
CX93488-5MG (±)-sorgolactone (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one Not available 316.35 C18 H20 O5 racemic sorgolactone >98% 5 MG 15000
CX64382-1MG (±)-strigol (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one 51820-11-2 346.37 C19 H22 O6   >98% 1 MG 5000
CX64382-5MG (±)-strigol (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one 51820-11-2 346.37 C19 H22 O6   >98% 5 MG 18800
CX88057-10MG Nijmegen-1 (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate 159155-03-0 343.29 C17 H13 N O7   >98% 10 MG 3600
CX88057-50MG Nijmegen-1 (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate 159155-03-0 343.29 C17 H13 N O7   >98% 50 MG 11800
CX42450-200MG (S)-beta2-homophenylalanine HCl salt (S)-3-amino-2-benzylpropanoic acid hydrochloride 1010806-95-7 215.68 C10 H14 Cl N O2 (S)-beta2-hPhe-OH · HCl >98% 200 MG 4800
CX42450-500MG (S)-beta2-homophenylalanine HCl salt (S)-3-amino-2-benzylpropanoic acid hydrochloride 1010806-95-7 215.68 C10 H14 Cl N O2 (S)-beta2-hPhe-OH · HCl >98% 500 MG 9800
CX42450-1G (S)-beta2-homophenylalanine HCl salt (S)-3-amino-2-benzylpropanoic acid hydrochloride 1010806-95-7 215.68 C10 H14 Cl N O2 (S)-beta2-hPhe-OH · HCl >98% 1 G 16000
CX35419-200MG (S)-beta2-homovaline HCl salt (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride Not available 167.63 C6 H14 Cl N O2 (S)-beta2-hVal-OH · HCl >98% 200 MG 4800
CX35419-500MG (S)-beta2-homovaline HCl salt (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride Not available 167.63 C6 H14 Cl N O2 (S)-beta2-hVal-OH · HCl >98% 500 MG 9800
CX35419-1G (S)-beta2-homovaline HCl salt (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride Not available 167.63 C6 H14 Cl N O2 (S)-beta2-hVal-OH · HCl >98% 1 G 16000
CX11583-200MG (R)-beta2-homophenylalanine HCl salt (R)-3-amino-2-benzylpropanoic acid hydrochloride Not available 215.68 C10 H14 Cl N O2 (R)-beta2-hPhe-OH · HCl >98% 200 MG 4800
CX11583-500MG (R)-beta2-homophenylalanine HCl salt (R)-3-amino-2-benzylpropanoic acid hydrochloride Not available 215.68 C10 H14 Cl N O2 (R)-beta2-hPhe-OH · HCl >98% 500 MG 9800
CX11583-1G (R)-beta2-homophenylalanine HCl salt (R)-3-amino-2-benzylpropanoic acid hydrochloride Not available 215.68 C10 H14 Cl N O2 (R)-beta2-hPhe-OH · HCl >98% 1 G 16000
CX92224-200MG (S)-beta2-homoleucine HCl salt (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride Not available 181.66 C7 H16 Cl N O2 (S)-beta2-hLeu-OH · HCl >98% 200 MG 4800
CX92224-500MG (S)-beta2-homoleucine HCl salt (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride Not available 181.66 C7 H16 Cl N O2 (S)-beta2-hLeu-OH · HCl >98% 500 MG 9800
CX92224-1G (S)-beta2-homoleucine HCl salt (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride Not available 181.66 C7 H16 Cl N O2 (S)-beta2-hLeu-OH · HCl >98% 1 G 16000
CX81018-500MG (S)-Fmoc-beta2-homoalanine (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid 203854-58-4 325.36 C19 H19 N O4 (S)-Fmoc-beta2-hAla-OH >98% 500 MG 11200
CX81018-1G (S)-Fmoc-beta2-homoalanine (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid 203854-58-4 325.36 C19 H19 N O4 (S)-Fmoc-beta2-hAla-OH >98% 1 G 18400
CX85919-500MG (R)-Fmoc-beta2-homoalanine (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid Not available 325.36 C19 H19 N O4 (R)-Fmoc-beta2-hAla-OH >98% 500 MG 11200
CX85919-1G (R)-Fmoc-beta2-homoalanine (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid Not available 325.36 C19 H19 N O4 (R)-Fmoc-beta2-hAla-OH >98% 1 G 18400
CX98774-500MG (R)-Fmoc-beta2-homoleucine (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid 1018899-99-4 367.44 C22 H25 N O4 (R)-Fmoc-beta2-hLeu-OH >98% 500 MG 11200
CX98774-1G (R)-Fmoc-beta2-homoleucine (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid 1018899-99-4 367.44 C22 H25 N O4 (R)-Fmoc-beta2-hLeu-OH >98% 1 G 18400
CX33604-500MG (R)-Fmoc-beta2-homovaline (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid Not available 353.41 C21 H23 N O4 (R)-Fmoc-beta2-hVal-OH >98% 500 MG 11200
CX33604-1G (R)-Fmoc-beta2-homovaline (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid Not available 353.41 C21 H23 N O4 (R)-Fmoc-beta2-hVal-OH >98% 1 G 18400
CX82946-500MG (S)-Fmoc-beta2-homophenylalanine (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid 203854-62-0 401.45 C25 H23 N O4 (S)-Fmoc-beta2-hPhe-OH >98% 500 MG 11200
CX82946-1G (S)-Fmoc-beta2-homophenylalanine (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid 203854-62-0 401.45 C25 H23 N O4 (S)-Fmoc-beta2-hPhe-OH >98% 1 G 18400
CX86231-500MG (S)-Fmoc-beta2-homovaline (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid 203854-59-5 353.41 C21 H23 N O4 (S)-Fmoc-beta2-hVal-OH >98% 500 MG 11200
CX86231-1G (S)-Fmoc-beta2-homovaline (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid 203854-59-5 353.41 C21 H23 N O4 (S)-Fmoc-beta2-hVal-OH >98% 1 G 18400
CX15046-500MG (R)-Fmoc-beta2-homophenylalanine (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid 828254-16-6 401.45 C25 H23 N O4 (R)-Fmoc-beta2-hPhe-OH >98% 500 MG 11200
CX15046-1G (R)-Fmoc-beta2-homophenylalanine (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid 828254-16-6 401.45 C25 H23 N O4 (R)-Fmoc-beta2-hPhe-OH >98% 1 G 18400
CX30199-500MG (S)-Fmoc-beta2-homoleucine (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid 193887-45-5 367.44 C22 H25 N O4 (S)-Fmoc-beta2-hLeu-OH >98% 500 MG 11200
CX30199-1G (S)-Fmoc-beta2-homoleucine (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid 193887-45-5 367.44 C22 H25 N O4 (S)-Fmoc-beta2-hLeu-OH >98% 1 G 18400
CX20422-1ML cereulide (50 µg/mL in acetonitrile) cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 (50 µg/mL in acetonitrile) Not available 1153.40 C57 H96 N6 O18 cereulide stock solution >95% 1 ML 5000
CX87778-1ML 13C6-cereulide (20 µg/mL in acetonitrile) cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 (20 µg/mL in acetonitrile) Not available 1159.36 C51 13 C6 H96 N6 O18 13C6-cereulide stock solution >95% 1 ML 5000
CX18112-1G 4-(azidomethyl)benzoic acid 4-(azidomethyl)benzoic acid 79584-03-5 177.16 C8 H7 N3 O2   >98% 1 G 3000
CX18112-5G 4-(azidomethyl)benzoic acid 4-(azidomethyl)benzoic acid 79584-03-5 177.16 C8 H7 N3 O2   >98% 5 G 7400
CX18112-10G 4-(azidomethyl)benzoic acid 4-(azidomethyl)benzoic acid 79584-03-5 177.16 C8 H7 N3 O2   >98% 10 G 13200
CX95981-5G 2,2,2-trichloroethoxysulfonyl chloride 2,2,2-trichloroethoxysulfonyl chloride 764-09-0 247.91 C2 H2 Cl4 O2 S chlorosulfuric acid 2,2,2-trichloroethyl ester >98% 5 G 2200
CX95981-10G 2,2,2-trichloroethoxysulfonyl chloride 2,2,2-trichloroethoxysulfonyl chloride 764-09-0 247.91 C2 H2 Cl4 O2 S chlorosulfuric acid 2,2,2-trichloroethyl ester >98% 10 G 4000
CX95981-25G 2,2,2-trichloroethoxysulfonyl chloride 2,2,2-trichloroethoxysulfonyl chloride 764-09-0 247.91 C2 H2 Cl4 O2 S chlorosulfuric acid 2,2,2-trichloroethyl ester >98% 25 G 8400
CX62483-1G 2-(azidomethyl)benzoic acid 2-(azidomethyl)benzoic acid 289712-57-8 177.16 C8 H7 N3 O2   >98% 1 G 4200
CX62483-2G 2-(azidomethyl)benzoic acid 2-(azidomethyl)benzoic acid 289712-57-8 177.16 C8 H7 N3 O2   >98% 2 G 7600
CX62483-5G 2-(azidomethyl)benzoic acid 2-(azidomethyl)benzoic acid 289712-57-8 177.16 C8 H7 N3 O2   >98% 5 G 16000
CX80461-1G 3-(azidomethyl)benzoic acid 3-(azidomethyl)benzoic acid 905973-32-2 177.16 C8 H7 N3 O2   >98% 1 G 4200
CX80461-2G 3-(azidomethyl)benzoic acid 3-(azidomethyl)benzoic acid 905973-32-2 177.16 C8 H7 N3 O2   >98% 2 G 7600
CX80461-5G 3-(azidomethyl)benzoic acid 3-(azidomethyl)benzoic acid 905973-32-2 177.16 C8 H7 N3 O2   >98% 5 G 16000
CX27597-1G 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate 1185733-70-3 457.66 C8 H10 Cl3 F3 N2 O6 S2   >98% 1 G 2600
CX27597-5G 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate 1185733-70-3 457.66 C8 H10 Cl3 F3 N2 O6 S2   >98% 5 G 9800
CX50506-10MG TIS108 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one Not available 335.40 C20 H21 N3 O2   >98% 10 MG 3600
CX50506-50MG TIS108 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one Not available 335.40 C20 H21 N3 O2   >98% 50 MG 13800
CX50506-100MG TIS108 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one Not available 335.40 C20 H21 N3 O2   >98% 100 MG 23000
CX95469-10MG 4-Br debranone 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one 1332863-94-1 269.09 C11 H9 Br O3 4BD >98% 10 MG 3000
CX95469-50MG 4-Br debranone 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one 1332863-94-1 269.09 C11 H9 Br O3 4BD >98% 50 MG 11400
CX95469-100MG 4-Br debranone 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one 1332863-94-1 269.09 C11 H9 Br O3 4BD >98% 100 MG 19600
CX75854-10MG 4-CN debranone 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one 1332863-97-4 215.20 C12 H9 N O3   >98% 10 MG 3000
CX75854-50MG 4-CN debranone 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one 1332863-97-4 215.20 C12 H9 N O3   >98% 50 MG 11400
CX75854-100MG 4-CN debranone 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one 1332863-97-4 215.20 C12 H9 N O3   >98% 100 MG 19600
CX52612-10MG Abamine oxalic acid salt (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate Not available 463.45 C23 H26 F N O8   >98% 10 MG 3000
CX52612-50MG Abamine oxalic acid salt (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate Not available 463.45 C23 H26 F N O8   >98% 50 MG 11400
CX52612-100MG Abamine oxalic acid salt (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate Not available 463.45 C23 H26 F N O8   >98% 100 MG 19600
CX93797-10G Fmoc-D-cyclohexylglycine (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid 198543-96-3 379.45 C23 H25 N O4 Fmoc-D-Chg-OH >97% 10 G 6000
CX93797-25G Fmoc-D-cyclohexylglycine (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid 198543-96-3 379.45 C23 H25 N O4 Fmoc-D-Chg-OH >97% 25 G 13000
CX29693-10G Fmoc-L-cyclohexylglycine (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid 161321-36-4 379.45 C23 H25 N O4 Fmoc-L-Chg-OH >97% 10 G 6000
CX29693-25G Fmoc-L-cyclohexylglycine (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid 161321-36-4 379.45 C23 H25 N O4 Fmoc-L-Chg-OH >97% 25 G 13000

Gene Universal Taq-DNA聚合酶

发表于由

 

Gene Universal位于美国特拉华州，是基因合成领域的。作为基因组学研究和应用生物技术的企业，基因环球拥有强大的技术力量。我们以的定制化服务和快捷的交货期，致力于提供更具成本效益的服务和产品，加速在药物发现、生物优化、食品和农业等领域的研究。
基因工程是基因工程、生物系统工程和合成生物学领域的专业。通过提供我们工业化、高强度的基因合成平台，利用*的技术，我们可以在短时间内同时传递正常和复杂的基因。我们还开发了复杂的软件程序来设计和优化复杂的基因库和基因系统。有了这些生物信息学工具和我们高效的生产管理，我们能够以高效、低成本、大规模的合成和组装基因和基因组dna来满足科研人员的需求。
同时，我们开发了多种重组蛋白平台。基于五种表达系统：细菌表达、哺乳动物表达（293&amp;CHO）、酵母表达、昆虫表达和枯草芽孢杆菌表达系统，我们已成为您基因合成、蛋白质表达和抗体生产服务的一站式供应商。
我们的长期目标是成为dna合成和合成领域的，实现生命科学研究更高效、生物产业生产成本更低的繁荣前景。

 

Gene Universal Taq-DNA聚合酶
我公司生产的Taq-DNA聚合酶是采用基因改造技术生产的高保真DNA聚合酶，提高了PCR扩增效率和扩增特异性。扩增产物的3'端“A”碱基可直接克隆到T载体中。
优势
高保真度
功能强大，优化少
酶少，产量高
基因组DNA片段扩增（1Kb/min）

Using references

Product specification

Product Names Catalog Size Price
Taq DNA Polymerase PM07050 500U $25
PM07100 1000U $40
PM07200 2000U $75